rfhg_205264.1

Basic information about the TSS

---

TSS ID: rfhg_205264.1 Species: human Chr: chr19		Start: 1249754 End: 1249769 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3031723,EH38E1931024)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000591446.6:119 BC094778:119 BC060848:119 GeneID: 90007 HGNC/MGI_ID: HGNC:16298 UniProt_ID: Q504T8 Nearer transcript ids and distances:

Gene_name: midnolin Gene_symbol: MIDN Gene_synonyms: Stx Gene_source: HGNC:16298

TATA-Box annotation

---

Distance to TSS:	1208
Nearest PromoterID:	NM_177401
Entrez ID:	90007
Nearest Unigene:	Hs.465529
Nearest Refseq:	NM_177401
Nearest Ensembl:	ENSG00000167470
Gene Name:	midnolin
Gene Alias:	-
Gene Type:	protein-coding
CpG%:	0.200000
GC%:	0.812500
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@MIDN p2@MIDN p3@MIDN p4@MIDN p5@MIDN p6@MIDN p7@MIDN p8@MIDN p9@MIDN
Sample		p1@MIDN	p2@MIDN	p3@MIDN	p4@MIDN	p5@MIDN	p6@MIDN	p7@MIDN	p8@MIDN	p9@MIDN
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	131.10	20.26	7.99	25.32	5.84	0.78	1.36	2.34	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	145.06	24.08	9.31	30.95	7.89	0.40	2.23	2.63	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	144.87	18.90	9.26	29.51	10.22	0.39	0.96	1.54	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	107.07	20.38	8.94	29.52	4.99	0.21	0.62	1.25	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	121.03	22.72	7.87	20.92	5.40	0.45	2.02	2.92	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	117.84	25.58	4.85	21.32	5.43	0.78	1.55	0.97	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	63.40	20.70	5.23	14.82	2.61	0.44	1.53	0.65	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	65.64	15.99	5.81	13.81	1.70	0.73	1.21	3.15	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	63.05	14.53	3.63	6.63	2.14	0.85	1.50	1.71	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	58.54	13.33	3.48	8.69	1.16	0.58	2.32	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	48.91	11.72	4.85	14.15	1.21	0.00	0.40	0.81	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	57.32	19.51	4.88	13.42	2.85	0.00	0.81	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	18.38	7.74	2.74	3.87	2.58	0.64	0.00	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	13.83	7.07	1.65	2.26	0.90	0.60	0.30	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	13.17	8.12	1.76	2.42	0.66	0.44	0.44	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	13.08	11.57	4.28	4.53	1.51	0.25	0.50	0.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	14.63	8.74	3.93	2.84	0.66	0.22	0.66	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	13.08	12.65	3.80	5.06	2.11	0.42	0.42	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	28.79	25.06	5.86	5.86	2.67	1.07	0.00	1.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	24.37	23.02	3.61	7.22	2.71	0.90	0.75	0.75	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	24.86	24.06	3.88	4.28	2.41	0.53	0.67	0.53	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	39.19	40.74	6.04	12.26	5.01	1.38	0.69	0.86	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	30.89	34.38	4.78	8.40	2.46	0.52	0.52	2.20	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	34.46	33.25	8.98	12.13	4.61	1.21	1.21	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	43.34	47.47	10.58	15.74	4.90	1.29	1.55	1.81	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	37.98	51.91	12.98	16.46	3.17	0.95	1.27	0.95	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	34.07	46.70	7.69	13.74	3.85	1.10	2.20	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	42.67	40.55	3.77	9.67	2.83	0.71	3.54	1.18	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	32.47	33.76	5.01	13.57	7.11	1.78	0.65	1.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	25.15	32.03	4.71	11.04	3.44	0.54	1.45	1.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	11.93	8.79	3.35	4.19	2.93	0.42	1.47	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	12.11	12.31	3.13	4.88	1.37	0.39	0.59	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	11.18	9.07	2.95	6.12	3.80	0.21	1.06	0.42	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	4.78	3.79	0.82	2.80	0.82	0.16	0.99	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	8.41	5.61	1.12	2.62	0.93	0.00	0.37	0.56	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	5.17	4.79	1.72	1.92	0.57	0.00	0.38	0.00	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	1.23	2.45	0.00	0.82	0.00	0.20	0.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	1.61	1.41	0.81	0.60	0.00	0.20	1.01	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	3.51	2.16	0.27	0.81	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	4.32	1.68	1.20	0.72	0.00	0.24	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	4.23	2.12	0.71	0.47	0.24	0.47	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	5.27	3.22	0.59	0.44	0.59	0.44	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	8.22	5.27	2.11	2.74	0.63	0.42	0.21	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	9.97	5.94	1.75	1.75	1.22	0.52	0.17	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	9.84	4.22	1.81	1.61	0.20	0.00	0.20	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	10.00	5.12	2.33	3.02	1.40	0.47	0.23	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	7.44	6.48	2.64	3.12	0.24	0.72	0.00	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	7.15	5.96	2.68	3.87	0.30	0.30	0.60	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	11.49	8.86	1.91	0.96	0.48	0.24	0.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	9.50	9.50	1.21	2.63	0.40	1.01	0.00	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	16.40	7.38	1.43	3.07	2.87	0.00	0.00	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	15.57	8.23	2.00	6.67	1.56	0.44	0.22	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	13.99	13.99	13.99	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	15.61	6.39	1.06	3.55	1.42	0.35	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	8.62	6.63	2.65	4.97	0.99	0.33	0.00	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	11.75	4.19	1.68	5.03	4.19	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	9.18	3.67	0.92	3.21	2.30	0.00	0.00	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	9.08	9.72	2.59	4.54	1.94	0.65	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	11.88	8.03	5.78	7.07	1.93	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	10.69	5.66	3.46	3.46	2.51	0.94	0.00	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	14.10	7.76	2.12	7.76	4.94	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	7.29	8.41	2.80	8.41	1.12	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	21.50	5.57	7.96	9.55	4.78	0.80	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	10.87	7.47	2.04	5.78	2.72	0.68	0.34	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	11.05	10.40	6.82	8.12	2.60	0.97	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	13.49	7.45	4.97	5.68	2.48	0.71	0.35	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	48.49	0.00	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	0.00	15.79	15.79	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	16.58	8.78	2.93	6.34	4.39	0.49	0.00	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	12.40	10.41	2.98	4.46	1.49	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	15.95	10.79	5.16	9.85	1.41	0.94	1.41	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	16.89	5.96	0.66	5.96	3.31	0.00	0.66	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	11.45	4.33	6.50	7.11	1.86	0.31	0.31	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	12.54	5.20	2.14	4.28	1.83	0.61	0.00	0.61	0.00
Adipocyte - breast, donor1	11376-118A8	21.86	13.30	5.07	1.74	0.32	0.16	0.32	0.79	0.00
Adipocyte - breast, donor2	11327-117E4	25.51	12.99	6.26	4.65	1.60	0.16	0.16	1.60	0.00
Adipocyte - omental, donor1	11473-119C6	22.77	12.34	3.82	1.65	0.64	0.13	0.64	0.76	0.00
Adipocyte - omental, donor2	11474-119C7	13.45	4.48	0.75	1.49	0.75	0.00	0.75	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	12.73	6.70	0.33	2.68	0.00	0.00	0.33	1.34	0.00
Adipocyte - perirenal, donor1	11476-119C9	17.86	6.38	1.28	0.64	0.00	1.28	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	13.19	6.60	0.00	0.00	1.10	0.00	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	14.45	3.16	0.90	0.00	0.00	0.00	0.45	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	23.63	16.51	4.17	4.69	0.00	0.17	0.35	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	38.53	20.93	7.63	1.76	0.59	0.39	1.17	0.59	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	53.79	20.59	4.12	3.60	0.51	0.51	1.29	0.51	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	28.43	9.76	4.46	4.18	0.56	0.28	0.84	1.12	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	31.74	17.63	8.23	1.76	0.00	0.00	1.18	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	15.36	17.21	1.45	1.13	0.24	0.32	0.56	0.40	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	26.47	10.97	0.65	6.46	0.00	0.00	0.65	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	13.86	12.26	2.13	2.67	0.00	0.00	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	10.02	12.80	2.78	2.23	0.56	0.00	1.11	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	11.64	9.98	0.83	1.25	0.42	0.42	0.83	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	17.33	10.30	5.02	1.26	1.00	0.00	0.50	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	13.42	6.87	2.29	1.64	0.65	0.00	0.65	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	10.35	9.44	2.13	1.83	0.30	0.00	1.22	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	42.65	26.96	2.21	2.65	0.66	1.10	1.33	0.44	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	45.18	25.10	3.59	8.96	2.51	0.00	1.79	1.43	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	32.35	9.58	2.40	2.40	1.20	1.20	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	29.68	16.19	2.16	3.06	0.54	0.36	0.00	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	15.06	18.41	1.67	5.02	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	28.76	21.78	2.67	2.05	0.62	0.41	0.82	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	57.56	21.63	6.29	6.64	0.92	0.23	0.23	0.46	0.00
Anulus Pulposus Cell, donor2	11463-119B5	51.92	10.53	3.67	4.90	0.98	0.00	0.49	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	7.64	6.74	5.84	4.49	0.00	0.00	0.00	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	10.42	7.81	2.60	3.91	0.87	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	0.00	8.56	4.28	0.00	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	17.04	7.47	5.98	4.48	0.00	0.30	0.90	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	12.65	6.32	3.79	5.06	1.26	0.00	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	7.26	4.62	5.94	6.60	0.00	0.00	0.00	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	8.12	9.10	3.90	4.22	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	10.68	3.88	6.31	5.83	0.49	0.49	0.97	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.31	6.53	3.56	7.72	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	9.04	4.52	3.77	3.01	0.00	0.00	0.00	0.75	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	8.71	7.26	7.26	4.35	0.73	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	8.78	6.27	3.76	5.02	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	9.55	7.58	0.99	0.49	0.00	0.16	0.33	0.16	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	6.82	6.82	6.82	2.73	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	4.22	4.83	1.96	1.06	0.15	0.15	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	10.72	6.43	3.75	6.43	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	9.82	8.31	5.67	6.61	0.38	0.19	0.19	0.38	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	11.49	6.95	3.74	7.75	0.27	0.00	0.27	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	12.68	11.71	6.83	0.00	0.00	0.00	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	6.14	4.48	2.65	3.32	0.17	0.00	0.50	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	12.01	6.00	4.80	3.60	1.20	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	3.54	0.00	3.54	0.00	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	7.72	5.66	3.95	4.63	0.34	0.17	0.34	0.34	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	4.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	15.05	6.31	3.40	6.80	0.49	0.00	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	7.59	6.45	2.28	3.79	0.76	0.38	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	12.11	3.63	4.85	6.06	1.21	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	9.69	3.42	3.42	2.28	0.57	0.00	0.00	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	8.55	5.77	4.06	4.92	0.21	0.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	5.42	3.10	4.90	5.16	0.26	0.00	0.00	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	13.61	5.16	4.69	3.28	0.47	0.00	0.00	1.41	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	9.65	6.75	4.18	8.04	0.00	0.00	0.00	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	10.70	3.57	4.28	7.13	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	8.77	2.92	2.92	2.92	0.58	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	7.83	7.53	4.82	4.52	0.60	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	11.88	4.75	5.94	4.75	1.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	11.70	5.09	4.07	7.63	0.00	0.51	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	6.62	5.60	5.35	6.88	0.51	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	6.35	2.54	2.54	3.18	0.64	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	8.63	6.04	3.02	7.34	0.43	0.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	7.20	6.56	4.66	4.45	0.21	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	3.19	4.35	4.06	3.77	0.00	0.29	0.00	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	8.50	2.83	3.78	7.56	0.00	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	5.93	5.42	3.56	2.88	0.00	0.34	0.00	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	9.27	2.32	0.00	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	4.23	4.23	10.56	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	8.79	6.43	4.07	4.29	0.21	0.00	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	5.41	4.81	4.81	5.41	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	13.12	5.10	2.92	2.19	0.73	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	7.82	5.75	1.84	2.99	1.38	0.46	0.00	0.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	10.20	0.00	5.10	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	3.05	4.58	2.03	1.78	0.51	0.00	0.25	0.51	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	5.37	4.34	2.89	3.92	0.41	0.62	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	8.57	5.51	6.12	4.90	0.00	0.31	0.31	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	8.60	7.17	2.87	7.17	0.96	0.00	0.00	0.96	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	11.31	6.43	3.77	4.66	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	6.10	6.10	12.21	3.05	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	8.86	6.65	6.65	2.77	0.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	9.53	7.68	3.97	4.24	0.53	0.00	0.26	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	3.27	6.54	7.27	6.18	0.36	0.36	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	57.36	13.02	0.86	1.60	0.25	0.49	0.74	0.49	0.00
Astrocyte - cerebellum, donor2	11580-120F5	49.12	10.27	2.40	4.96	0.68	0.17	1.03	1.03	0.00
Astrocyte - cerebellum, donor3	11661-122F5	51.60	18.46	7.76	2.94	0.21	0.84	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	44.62	11.15	5.23	3.14	0.70	1.05	0.70	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	53.55	18.93	6.15	5.18	0.97	1.46	0.97	0.65	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	43.85	17.45	4.18	7.91	1.04	1.34	0.00	0.60	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	48.05	9.29	4.24	4.47	0.57	1.26	0.46	0.23	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	53.87	9.77	4.51	3.26	0.50	1.00	0.50	0.38	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	42.45	7.28	2.28	3.07	0.23	0.91	0.11	0.46	0.34
Basophils, donor1	12241-129G9	281.93	109.32	5.23	8.37	2.88	9.68	0.52	2.09	21.97
Basophils, donor2	12242-129H1	239.93	66.03	4.33	6.86	2.16	6.86	0.00	1.08	21.29
Basophils, donor3	12243-129H2	172.72	129.80	13.23	9.41	1.47	6.76	0.44	1.62	19.55
Bronchial Epithelial Cell, donor1	11511-119G8	39.02	23.29	3.02	1.72	0.00	0.22	1.29	0.86	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	53.49	26.06	5.03	7.77	1.83	0.00	3.20	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	0.00	14.35	28.69	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	21.97	18.20	0.00	2.51	0.00	0.00	1.26	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	26.20	18.72	2.70	2.08	0.21	0.21	1.46	1.25	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	28.10	20.04	3.45	2.30	0.23	0.00	2.76	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	18.71	9.00	5.58	5.76	0.72	0.36	1.62	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	38.75	11.65	2.99	1.85	0.10	0.93	0.62	0.10	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	62.65	11.88	8.38	5.12	0.70	1.40	1.40	1.16	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	28.78	17.27	2.24	1.60	0.32	3.52	0.00	0.00	6.08
CD133+ stem cells - cord blood derived, pool1	12223-129E9	62.05	51.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	105.95	57.48	8.45	8.45	0.56	7.33	0.56	2.25	12.96
CD14+ Monocytes, donor2	11305-117B9	140.50	77.58	26.17	12.44	5.38	8.17	0.00	4.27	12.44
CD14+ Monocytes, donor3	11381-118B4	121.18	79.47	21.30	33.81	4.61	6.81	0.00	1.76	8.78
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	34.25	9.34	1.70	1.42	0.28	0.57	0.28	0.57	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	29.57	5.31	1.90	1.14	1.14	0.00	0.38	0.38	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	37.81	13.81	3.29	2.30	0.00	0.33	0.00	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	133.85	72.27	25.30	22.26	4.34	1.01	2.75	6.50	4.48
CD14+ monocytes - mock treated, donor2	11873-125C1	96.86	67.29	11.77	14.79	2.41	1.51	3.32	3.32	3.92
CD14+ monocytes - mock treated, donor3	11883-125D2	132.42	75.10	12.56	16.11	1.42	1.90	4.97	2.13	4.74
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	82.02	73.15	19.75	13.56	2.85	1.84	1.84	2.68	4.69
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	48.85	75.90	12.42	12.97	1.38	1.66	1.38	1.10	8.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	64.96	78.59	7.19	14.13	1.49	2.48	0.50	2.73	9.42
CD14+ monocytes - treated with BCG, donor1	11860-125A6	86.94	83.02	32.31	24.08	2.35	1.57	3.13	4.11	3.92
CD14+ monocytes - treated with BCG, donor2	11870-125B7	83.86	83.68	20.12	14.78	2.49	1.07	3.03	3.20	4.45
CD14+ monocytes - treated with BCG, donor3	11880-125C8	73.12	75.95	3.26	6.09	0.87	0.65	2.61	1.09	6.53
CD14+ monocytes - treated with Candida, donor1	11868-125B5	34.88	54.55	8.43	4.92	0.70	0.94	0.00	0.94	3.51
CD14+ monocytes - treated with Candida, donor2	11878-125C6	33.79	60.20	3.17	3.17	0.00	2.64	1.58	0.53	11.62
CD14+ monocytes - treated with Candida, donor3	11888-125D7	42.16	59.91	5.55	2.22	0.00	2.22	1.11	1.11	9.98
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	105.91	82.85	29.15	20.82	4.91	1.49	2.38	5.21	7.29
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	67.65	69.24	8.78	10.38	2.59	0.80	1.80	1.20	4.59
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	57.67	53.51	3.54	4.58	0.00	0.62	0.21	1.04	4.16
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	51.71	76.87	16.01	14.87	2.97	0.92	1.60	3.66	5.95
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	35.51	66.28	1.58	3.62	1.36	0.45	2.04	1.36	4.07
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	34.04	69.83	3.93	8.29	0.44	0.00	2.62	1.31	3.49
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	163.28	61.60	24.75	13.18	2.15	0.54	0.81	4.03	2.42
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	130.32	94.73	26.17	21.63	2.62	2.44	2.27	5.23	3.49
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	154.86	67.75	17.67	16.41	4.21	1.68	4.63	4.63	2.95
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	52.91	45.74	12.68	11.02	3.12	0.73	0.73	2.57	4.04
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	35.58	46.15	4.23	4.23	0.35	1.06	1.06	2.47	3.52
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	47.38	53.52	3.95	8.77	3.07	2.19	1.32	2.63	5.26
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	99.92	91.20	34.18	32.26	3.49	2.27	2.79	3.31	7.67
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	95.52	98.87	24.16	29.73	7.43	2.97	3.35	4.83	6.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	90.96	96.78	5.17	7.98	1.51	1.94	2.37	2.59	13.15
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	61.42	32.35	9.83	6.55	0.82	0.00	0.41	0.00	1.64
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	28.05	32.22	0.93	0.70	0.46	0.46	0.23	0.23	1.85
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	31.32	35.03	2.32	1.86	0.23	0.70	0.70	0.46	1.86
CD14+CD16+ Monocytes, donor1	11789-124B7	130.56	40.54	3.92	2.62	1.09	2.40	0.44	0.00	2.62
CD14+CD16+ Monocytes, donor2	11801-124D1	185.49	69.07	6.93	2.77	1.62	2.77	0.69	2.77	3.46
CD14+CD16+ Monocytes, donor3	11912-125G4	111.56	37.69	1.30	1.73	0.43	2.38	0.43	0.65	1.30
CD14+CD16- Monocytes, donor1	11788-124B6	196.68	75.53	4.98	4.05	2.80	5.45	0.31	1.87	2.18
CD14+CD16- Monocytes, donor2	11799-124C8	166.96	59.55	8.38	5.59	1.92	3.49	0.52	1.75	2.97
CD14+CD16- Monocytes, donor3	11910-125G2	185.06	47.27	1.56	4.01	1.78	3.79	0.00	0.67	2.01
CD14-CD16+ Monocytes, donor1	11790-124B8	236.29	65.84	6.63	1.28	0.00	2.04	2.04	0.51	3.06
CD14-CD16+ Monocytes, donor2	11800-124C9	247.67	61.48	6.15	1.54	1.98	3.07	1.10	1.10	3.07
CD14-CD16+ Monocytes, donor3	11911-125G3	171.17	42.11	4.84	4.42	1.05	2.32	0.63	0.84	1.68
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	28.45	2.03	2.03	0.00	0.00	0.00	0.00	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	38.64	6.10	1.36	0.00	0.68	0.68	0.68	0.00	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	38.32	4.14	2.07	1.04	0.00	2.07	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	65.56	4.26	2.67	1.60	0.00	1.07	0.53	0.00	2.13
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	31.09	3.75	0.00	0.00	0.00	0.00	0.54	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	32.29	2.81	0.00	0.70	0.00	0.00	0.00	0.00	2.11
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	29.81	1.57	0.78	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	47.46	5.27	0.00	0.00	0.00	0.00	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	150.41	9.04	9.86	8.22	0.00	4.11	0.00	1.64	13.97
CD19+ B Cells, donor2	11624-122B4	303.95	37.72	18.86	19.59	3.63	4.35	0.73	1.45	21.04
CD19+ B Cells, donor3	11705-123B4	285.23	19.69	15.65	14.64	0.50	1.51	1.51	3.53	17.67
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	13.33	5.25	0.40	0.00	0.00	0.81	0.40	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	14.38	6.39	0.80	0.40	0.00	1.20	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	117.47	60.24	0.00	3.01	2.01	3.01	1.00	0.00	55.22
CD34+ Progenitors, donor2	11625-122B5	82.59	34.27	0.00	2.81	1.12	6.18	0.56	0.00	55.62
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	26.68	4.51	1.50	1.88	0.00	0.00	0.00	0.75	1.88
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	29.54	6.09	1.13	0.90	0.00	1.58	0.00	0.23	1.13
CD4+ T Cells, donor1	11225-116C1	160.68	2.14	7.50	5.71	1.43	0.00	0.00	1.43	7.50
CD4+ T Cells, donor2	11306-117C1	208.20	6.12	30.62	14.70	2.45	0.61	0.00	1.22	16.53
CD4+ T Cells, donor3	11382-118B5	254.06	12.81	10.98	40.56	1.22	2.74	0.00	3.05	24.70
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	46.71	4.08	1.79	1.53	0.26	0.51	0.00	0.26	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	40.88	2.92	3.59	2.02	0.45	1.12	0.00	0.00	2.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	49.73	4.31	2.87	3.74	0.86	1.15	0.00	0.29	1.15
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	141.75	2.37	2.37	0.00	0.00	0.00	0.00	0.47	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	74.45	0.70	1.40	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	46.15	0.00	3.30	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	43.93	6.21	2.31	2.60	0.72	1.45	0.00	1.16	1.73
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	45.59	9.66	10.34	10.00	0.51	2.20	0.85	0.85	2.88
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	41.91	10.16	9.03	6.45	1.29	1.29	0.32	0.64	2.74
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	67.24	3.14	2.24	0.45	0.45	0.45	0.45	0.00	4.48
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	38.08	1.40	1.05	0.70	0.00	0.00	0.00	0.00	1.75
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	49.72	3.08	0.88	1.76	0.88	0.88	0.00	0.00	2.20
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	54.81	1.26	2.11	0.42	0.84	0.00	0.00	0.84	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	42.39	5.61	8.52	7.27	0.42	0.83	0.62	0.21	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	39.09	3.34	7.02	4.34	0.33	0.67	0.00	0.33	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	79.95	0.27	1.09	0.82	0.54	0.00	0.00	0.27	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	33.76	0.00	0.54	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	55.59	0.00	0.00	1.79	0.00	0.00	0.00	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	60.08	6.68	2.97	1.11	0.00	0.56	0.00	0.56	2.23
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	39.21	6.50	2.60	1.30	1.08	1.52	0.43	0.22	2.17
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	57.79	6.94	2.94	4.20	0.21	2.10	0.63	0.42	2.73
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	137.52	5.56	1.01	0.51	0.51	0.00	0.00	0.00	3.54
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	94.45	3.03	0.87	0.43	0.00	0.43	0.00	0.00	5.63
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	70.17	2.61	0.00	2.61	0.00	1.31	0.00	0.00	4.36
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	59.38	3.96	3.46	1.98	0.49	0.00	0.00	0.00	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	53.54	0.00	0.92	1.85	0.00	0.92	0.00	0.00	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	36.29	1.40	1.40	1.40	0.00	0.00	0.00	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	74.49	3.88	0.28	0.28	1.38	1.11	0.28	0.28	1.38
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	63.56	2.70	0.25	1.72	0.74	0.49	0.74	0.25	2.45
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	61.60	3.08	0.00	0.00	0.00	0.00	0.00	0.00	6.16
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	74.49	6.45	2.15	2.51	0.36	0.36	0.36	0.72	1.79
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	66.48	4.15	2.77	1.38	0.00	1.38	1.38	0.00	2.77
CD8+ T Cells, donor1	11226-116C2	379.78	18.99	21.94	15.39	2.29	2.95	0.65	3.60	30.78
CD8+ T Cells, donor2	11307-117C2	348.78	12.39	46.55	32.66	5.26	4.13	0.00	4.13	33.04
CD8+ T Cells, donor3	11383-118B6	307.28	11.36	15.15	36.61	4.04	2.02	0.76	3.03	22.72
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	17.89	23.17	3.21	8.72	1.61	1.38	0.00	0.23	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	18.45	24.44	5.03	5.75	2.40	0.96	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	19.70	20.25	2.46	7.11	1.37	0.82	0.27	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	18.61	15.31	3.30	9.61	1.20	0.60	0.00	0.60	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	26.88	25.92	3.84	9.36	1.92	1.44	0.24	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	22.28	27.97	2.50	7.50	1.36	0.68	0.00	1.59	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	25.86	24.12	4.56	6.52	1.96	0.87	0.00	1.30	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	26.85	28.43	4.21	7.37	1.84	1.32	0.53	1.05	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	25.80	23.45	3.28	7.97	1.88	0.00	0.00	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	24.75	26.57	4.23	9.96	1.81	0.60	1.21	1.21	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	24.69	26.73	3.20	10.17	1.74	0.87	0.00	0.29	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	24.25	24.51	3.20	6.13	1.60	2.40	0.00	0.27	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	69.60	79.23	4.38	24.51	0.44	2.19	1.31	1.75	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	81.07	86.99	6.38	12.75	0.46	0.91	0.91	0.91	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	77.57	72.35	6.71	18.65	0.75	2.24	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	29.17	28.45	1.80	9.00	2.16	2.52	0.00	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	20.43	26.76	4.32	14.10	0.58	2.30	0.00	0.86	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	24.28	29.70	3.30	8.01	0.71	1.65	0.00	1.41	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	29.47	32.01	1.58	8.24	0.95	0.63	0.00	0.95	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	37.52	35.37	3.08	8.61	0.92	2.77	0.62	0.92	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	28.85	25.65	2.24	8.98	0.64	1.92	0.32	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	25.24	21.80	0.76	8.80	1.91	1.53	0.00	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	29.16	23.25	1.18	5.12	0.79	0.00	0.00	0.79	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	14.37	17.40	3.03	3.03	0.76	0.76	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	73.07	111.61	5.62	21.68	4.01	1.61	1.61	0.80	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	74.14	114.71	6.99	17.49	1.40	1.40	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	94.16	128.22	5.01	17.03	2.00	3.01	0.00	1.00	1.00
Cardiac Myocyte, donor1	11525-119I4	107.84	20.11	10.97	12.79	1.83	0.00	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	39.03	9.39	5.43	6.42	0.49	0.00	0.49	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	31.36	10.63	2.95	1.05	0.11	0.11	0.21	0.21	0.00
Chondrocyte - de diff, donor1	11261-116G1	18.72	5.55	0.35	2.77	3.47	0.00	0.00	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	24.88	7.11	2.13	0.36	0.00	0.00	0.00	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	31.18	22.64	2.96	9.67	1.14	0.68	0.80	0.80	0.00
Chondrocyte - re diff, donor2	11339-117F7	27.75	8.06	0.90	0.00	0.00	0.00	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	42.06	29.12	0.40	3.64	0.00	0.00	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	34.89	17.56	4.36	3.67	0.34	0.92	0.69	0.23	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	23.09	17.96	7.27	5.34	0.64	0.43	0.64	0.86	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	30.27	16.64	2.12	4.78	0.44	0.97	0.88	0.71	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	52.91	35.67	3.03	1.83	0.64	1.47	1.10	1.01	0.28
Corneal Epithelial Cells, donor1	11526-119I5	57.75	21.30	3.51	2.42	0.00	0.22	1.32	0.44	0.00
Corneal Epithelial Cells, donor2	11606-120I4	35.27	28.44	5.69	4.55	1.14	0.00	4.55	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	35.28	16.36	4.09	6.14	0.51	0.26	2.05	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	31.37	15.02	3.63	1.32	0.00	0.33	0.66	0.17	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	29.96	15.77	3.47	1.58	0.00	0.32	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	10.35	0.00	0.00	3.45	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	24.19	17.82	1.73	4.86	0.76	0.65	0.97	0.43	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	182.09	24.26	13.32	5.47	0.68	3.76	0.00	1.02	1.37
Dendritic Cells - plasmacytoid, donor2	11309-117C4	132.53	18.93	0.65	1.96	0.00	2.61	0.00	0.00	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	150.99	13.07	0.48	1.45	0.00	1.45	0.00	0.97	1.94
Endothelial Cells - Aortic, donor0	11207-116A1	14.01	19.18	1.00	1.50	0.17	0.00	0.00	0.67	1.50
Endothelial Cells - Aortic, donor1	11263-116G3	12.91	14.67	1.76	0.00	0.00	0.00	0.00	0.00	2.35
Endothelial Cells - Aortic, donor2	11340-117F8	17.53	21.78	1.98	1.13	0.00	0.00	0.28	0.28	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	18.48	19.66	0.79	1.18	0.00	0.39	0.79	0.39	1.57
Endothelial Cells - Artery, donor1	11264-116G4	11.93	15.42	0.29	1.75	1.45	0.00	0.00	1.16	0.58
Endothelial Cells - Artery, donor2	11341-117F9	20.23	25.65	8.23	6.35	2.35	0.47	0.47	0.71	0.47
Endothelial Cells - Artery, donor3	11413-118E9	15.43	25.77	0.35	1.75	0.35	0.18	0.70	0.70	1.23
Endothelial Cells - Lymphatic, donor1	11236-116D3	8.20	16.85	1.33	0.89	0.22	0.00	0.44	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	6.69	11.56	0.91	0.00	0.00	0.00	0.30	0.30	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	7.05	12.97	0.28	0.28	0.00	0.00	0.00	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	6.24	9.21	0.89	1.49	0.89	0.00	0.30	0.00	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	9.37	10.93	3.12	0.52	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	7.94	13.47	0.85	2.41	0.14	0.57	0.43	0.28	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	15.20	12.40	1.20	4.00	1.20	0.00	0.40	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	19.92	19.39	7.34	5.77	1.05	0.00	0.52	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	25.97	17.77	2.48	1.62	0.50	0.87	0.37	0.37	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	14.77	15.64	4.13	1.09	0.22	0.65	0.65	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	14.17	18.20	1.10	1.59	0.12	0.12	0.49	0.24	0.12
Endothelial Cells - Vein, donor1	11267-116G7	27.30	13.65	1.14	1.14	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	23.75	22.35	0.70	0.70	0.00	0.70	0.00	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	16.49	29.67	0.94	3.77	0.16	1.10	1.10	0.63	0.63
Eosinophils, donor1	12244-129H3	152.47	15.25	0.00	0.00	0.00	0.00	0.00	15.25	0.00
Eosinophils, donor2	12245-129H4	1090.82	415.87	19.80	18.15	6.60	31.35	3.30	9.90	85.81
Eosinophils, donor3	12246-129H5	845.34	345.98	10.70	21.40	3.57	14.27	3.57	0.00	42.80
Esophageal Epithelial Cells, donor1	11507-119G4	36.89	18.57	2.69	0.73	0.24	0.00	0.98	0.49	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	31.20	4.16	2.08	8.32	0.00	0.00	4.16	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	24.22	12.73	6.57	4.52	0.82	0.00	0.82	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	6.57	4.16	1.64	3.28	1.09	0.11	0.11	0.33	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	20.58	11.70	3.36	12.89	5.31	0.43	0.33	0.87	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	31.05	17.46	3.40	2.91	0.97	0.12	0.24	1.33	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	23.88	20.88	0.96	1.36	0.27	0.14	0.41	0.14	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	25.31	11.18	3.06	3.27	0.53	0.11	0.74	0.53	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	47.16	16.86	0.26	0.79	0.26	0.26	1.58	0.79	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	42.52	20.60	4.65	5.98	1.66	0.33	0.66	0.33	0.66
Fibroblast - Cardiac, donor1	11268-116G8	21.32	7.26	1.36	3.63	0.00	0.00	1.81	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	29.56	16.67	3.79	3.03	0.76	0.76	0.00	1.52	0.00
Fibroblast - Cardiac, donor3	11417-118F4	20.82	15.77	1.73	5.05	0.63	0.00	0.32	0.47	0.00
Fibroblast - Cardiac, donor4	11452-119A3	39.10	10.00	1.21	0.91	0.30	0.00	0.91	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	24.49	13.96	1.90	3.93	0.63	0.13	1.27	0.38	0.13
Fibroblast - Cardiac, donor6	11460-119B2	18.95	12.58	2.27	2.43	0.45	0.76	1.36	0.00	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	36.31	7.37	0.94	1.21	0.13	0.13	0.67	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	22.87	6.90	4.31	0.43	0.86	0.86	0.43	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	24.90	7.32	7.32	8.79	2.93	1.46	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	39.21	9.46	1.15	0.69	0.00	0.23	0.69	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	47.49	14.76	1.53	0.68	0.51	0.17	0.34	0.51	0.00
Fibroblast - Dermal, donor1	11269-116G9	20.43	8.45	1.64	1.41	0.47	0.00	0.70	0.47	0.00
Fibroblast - Dermal, donor2	11346-117G5	17.45	5.66	0.94	0.94	0.47	0.00	0.47	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	24.06	11.85	0.73	4.84	1.09	0.12	0.24	0.97	0.00
Fibroblast - Dermal, donor4	11450-119A1	11.76	4.63	1.02	2.37	0.45	0.11	0.23	0.11	0.11
Fibroblast - Dermal, donor5	11454-119A5	21.81	7.15	1.57	2.79	0.70	0.17	0.52	0.35	0.00
Fibroblast - Dermal, donor6	11458-119A9	22.25	9.42	1.95	2.27	0.32	0.81	0.00	0.65	0.00
Fibroblast - Gingival, donor1	11237-116D4	38.11	15.62	3.33	0.62	0.21	0.21	0.62	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	36.94	23.06	0.79	3.41	1.31	0.00	0.52	0.52	0.00
Fibroblast - Gingival, donor2	11318-117D4	32.81	13.97	9.09	5.67	0.66	0.40	0.26	0.66	0.00
Fibroblast - Gingival, donor3	11394-118C8	58.69	26.01	1.84	2.80	0.48	0.48	1.06	0.77	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	32.21	20.78	2.08	5.19	3.12	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	37.00	13.74	9.87	4.76	1.76	0.18	1.23	0.88	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	34.30	18.24	2.81	2.81	0.31	0.31	0.47	0.47	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	34.21	12.71	2.16	1.76	0.14	0.14	0.54	0.68	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	104.10	48.34	0.35	1.41	1.06	0.71	1.41	3.53	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	36.71	15.06	2.05	3.22	0.73	0.29	0.58	0.73	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	28.36	13.64	2.59	2.73	0.68	0.41	0.55	0.27	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	31.70	23.04	1.54	2.74	0.99	0.22	0.33	0.66	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	61.04	18.64	2.49	3.08	2.05	0.73	0.59	1.17	0.00
Fibroblast - Lung, donor1	11270-116H1	43.50	20.39	1.36	1.36	0.00	1.36	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	55.21	19.40	4.48	1.49	1.49	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	35.24	20.26	3.38	8.86	1.69	0.42	0.00	0.42	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	59.14	14.16	0.83	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	23.78	1.40	1.40	0.00	0.00	0.00	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	31.07	9.52	1.96	1.12	0.00	0.00	0.84	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	46.28	17.05	0.81	0.00	0.00	0.41	1.22	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	27.96	7.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	5.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	31.04	12.03	4.07	2.13	0.58	0.39	0.58	0.19	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	39.89	14.26	2.73	1.82	0.91	0.76	0.76	0.46	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	26.31	11.63	1.84	0.00	0.00	0.61	0.92	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	33.96	8.40	1.53	2.67	0.76	0.00	0.38	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	29.97	14.85	9.72	2.70	0.54	0.27	0.54	0.81	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	39.08	17.16	2.90	5.91	0.70	0.00	1.28	0.93	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	18.46	15.03	3.87	4.09	0.33	0.33	0.33	0.22	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	44.50	12.60	1.22	0.41	0.41	0.20	0.61	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	36.08	8.02	4.01	5.35	2.00	0.00	0.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	29.65	14.23	3.56	3.95	0.79	0.00	0.40	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	48.22	24.81	0.79	1.98	2.18	0.00	0.40	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	28.24	8.88	1.24	0.53	0.00	0.00	0.89	0.71	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	31.14	8.87	2.17	0.59	0.39	0.20	0.59	0.39	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	38.51	18.05	1.50	2.41	0.60	0.30	0.00	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	28.28	9.39	0.97	1.84	0.54	0.32	0.43	0.11	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	48.34	17.21	1.27	2.28	2.02	0.25	0.25	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	21.49	9.68	1.64	1.48	0.33	0.00	0.16	0.66	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	36.09	30.28	4.81	2.81	0.60	0.40	0.40	0.20	0.20
Fibroblast - skin normal, donor2	11561-120D4	24.71	9.04	0.40	1.11	0.60	0.20	0.10	0.20	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	55.61	17.53	1.21	1.21	0.91	0.30	0.30	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	29.08	10.02	1.49	1.49	0.25	0.08	0.58	0.17	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	30.60	7.18	0.51	0.85	0.85	0.17	0.17	0.34	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	36.78	18.72	1.31	0.33	0.99	0.00	0.99	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	18.75	6.39	1.07	1.17	0.85	0.11	0.32	0.32	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	34.58	11.64	2.36	2.36	0.84	0.00	0.17	0.84	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	14.74	4.86	0.78	5.65	1.41	0.00	0.00	0.63	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	22.16	0.00	0.00	44.32	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	40.96	41.83	2.61	4.36	0.00	1.74	0.87	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	21.50	15.43	3.81	1.56	0.52	0.17	1.04	0.52	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	21.86	11.71	1.04	1.30	0.00	0.26	1.56	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	16.86	16.35	2.30	0.26	0.00	0.26	0.77	0.77	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	156.94	40.57	24.50	42.11	4.59	5.36	6.12	5.36	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	128.89	42.75	19.78	43.39	5.74	3.83	1.28	3.19	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	91.85	22.25	31.95	65.04	8.56	4.85	1.43	2.85	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	237.43	42.47	41.64	63.98	17.10	7.17	0.28	8.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	145.22	37.22	17.35	31.05	6.62	5.25	1.14	3.42	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	118.28	28.73	27.54	60.83	11.29	6.74	1.78	2.38	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	214.38	37.27	45.20	54.98	17.45	8.99	0.26	6.08	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	170.90	47.94	19.89	29.68	5.54	4.24	3.26	0.65	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	79.60	18.57	22.11	36.26	6.63	3.98	0.88	3.10	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	103.87	20.77	8.20	14.98	1.98	3.11	2.12	2.26	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	112.18	20.69	6.53	7.76	2.34	3.32	2.09	1.97	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	96.17	14.24	12.89	16.12	3.22	2.69	1.34	2.15	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	113.61	31.59	6.44	12.39	2.73	1.98	2.73	1.61	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	125.41	36.13	7.20	11.63	1.66	2.35	1.25	1.94	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	88.84	28.06	15.04	15.65	4.88	3.66	1.22	1.22	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	72.56	18.71	18.94	8.67	1.37	1.37	1.14	1.60	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	83.96	21.18	4.61	6.60	2.49	1.25	2.37	1.87	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	88.52	18.80	5.68	9.62	1.75	1.75	2.84	1.53	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	61.46	12.71	11.23	11.82	1.77	1.48	1.18	1.48	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	89.65	22.25	5.72	7.15	0.95	2.23	2.54	1.11	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	87.13	24.80	9.38	9.61	1.56	0.89	1.12	2.23	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	77.43	14.92	9.28	12.10	3.02	2.02	1.61	0.81	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	77.70	17.64	3.05	6.28	1.87	1.53	1.36	1.02	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	86.19	23.23	5.94	4.61	2.31	1.60	1.42	1.68	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	112.59	13.32	7.49	7.08	1.14	2.50	0.83	2.19	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	95.12	10.59	1.71	3.59	0.85	2.22	1.02	1.54	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	73.25	14.16	1.88	3.21	0.77	2.21	0.89	0.89	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	64.39	13.48	4.33	4.49	1.16	1.16	0.75	1.00	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	61.66	10.82	3.27	3.88	0.82	1.43	0.61	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	63.34	11.14	10.52	9.70	1.65	0.41	0.62	1.44	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	82.90	13.95	4.50	5.42	1.04	1.15	1.27	1.15	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	54.37	13.34	5.67	4.67	1.33	0.67	1.00	1.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	54.45	9.48	8.82	9.26	1.54	1.76	0.66	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	78.59	12.42	2.71	5.17	1.35	1.72	1.60	1.72	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	65.00	8.92	6.16	6.16	1.46	1.95	0.00	1.30	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	64.46	9.30	7.70	8.66	0.96	1.60	1.92	2.89	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	57.33	10.71	1.90	3.79	1.80	1.23	0.66	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	40.65	10.91	5.22	3.80	0.63	1.74	0.95	1.11	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	74.50	11.25	3.95	7.30	0.91	0.91	0.91	1.82	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	54.99	11.60	3.87	6.27	1.67	1.36	0.52	0.63	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	36.89	7.68	3.07	3.73	1.32	0.00	0.44	1.32	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	53.58	10.94	5.61	8.42	0.84	0.84	0.56	1.40	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	56.02	13.05	1.76	1.67	0.46	0.93	1.20	1.11	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	32.36	9.36	3.21	3.74	1.87	0.00	0.27	0.80	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	36.42	9.95	2.30	4.44	1.07	0.31	0.15	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	44.82	10.75	3.50	2.59	0.39	0.39	0.26	0.78	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	30.36	5.96	1.36	3.25	0.81	1.08	0.81	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	43.32	9.59	3.69	6.64	1.47	0.55	1.11	1.11	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	45.62	8.99	5.48	5.70	1.10	1.32	0.22	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	69.42	14.88	0.99	0.00	3.97	0.99	1.98	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	38.25	9.37	4.22	5.28	1.19	0.40	0.26	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	34.70	5.65	4.24	3.63	0.61	0.81	0.81	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	98.87	16.52	3.81	0.76	0.00	2.03	0.51	1.27	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	84.40	9.75	3.38	2.59	2.59	3.18	1.19	0.80	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	130.50	27.73	5.39	8.47	1.69	3.39	3.24	2.16	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	144.64	27.82	5.11	8.59	1.23	5.52	2.66	2.05	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	66.65	18.78	13.14	7.51	1.25	3.76	1.25	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	68.66	14.13	7.06	4.24	1.70	1.70	1.70	0.57	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	68.26	11.53	16.60	7.84	3.23	1.38	2.31	0.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	94.04	24.75	9.90	14.85	4.95	0.00	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	96.32	18.95	16.25	21.66	4.25	1.93	1.93	2.71	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	91.45	20.86	28.88	17.65	1.60	0.00	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	130.41	33.04	20.87	20.87	5.22	0.00	1.74	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	92.44	13.02	15.62	14.97	2.28	1.95	2.60	1.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	89.36	14.41	24.71	16.06	5.35	1.65	2.06	1.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	79.97	16.66	13.33	39.99	3.33	0.00	0.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	72.43	12.58	16.22	12.58	3.92	0.84	0.28	2.52	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	74.85	11.77	17.98	16.02	1.63	0.33	1.31	2.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	88.92	13.42	14.26	11.74	7.55	2.52	0.84	1.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	76.66	13.68	11.13	12.40	4.13	0.00	2.54	1.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	59.10	12.91	18.00	19.02	2.38	2.04	1.70	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	54.29	10.44	12.53	2.09	0.00	0.00	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	90.49	10.31	21.19	13.17	3.44	0.57	1.72	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	52.09	10.06	22.20	23.09	5.03	0.30	1.18	2.07	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	44.05	15.25	8.47	11.86	1.69	0.00	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	63.79	10.36	18.23	18.23	1.24	1.24	0.41	1.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	76.40	11.05	21.40	17.03	4.14	2.07	1.84	1.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	31.61	0.00	5.27	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	46.13	12.69	21.91	11.15	3.84	0.38	1.15	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	41.72	13.36	9.45	7.82	0.98	0.33	0.98	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	38.12	7.36	4.01	5.35	0.67	0.67	0.67	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	63.57	11.94	16.95	7.32	8.09	0.77	0.39	1.93	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	99.96	27.04	20.54	14.38	7.19	1.37	3.42	2.74	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	64.60	14.91	17.39	27.33	4.97	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	75.97	6.13	13.68	21.23	2.83	0.47	1.42	1.89	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	67.59	8.45	13.88	14.48	4.83	2.41	2.41	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	61.55	11.70	4.07	6.61	1.53	1.02	0.00	2.03	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	57.03	6.78	9.97	11.57	1.99	0.40	1.20	1.99	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	53.78	6.41	7.89	8.88	3.45	0.99	0.49	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	43.68	16.53	37.77	11.80	3.54	2.36	2.36	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	42.01	8.75	15.17	12.84	2.33	0.58	0.00	1.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	64.08	9.22	13.17	5.71	1.32	1.32	0.44	1.76	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	99.18	26.28	25.43	17.80	6.78	1.70	0.85	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	59.69	17.31	19.10	14.92	5.37	1.19	1.19	1.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	57.26	10.68	22.81	6.79	0.49	1.46	0.49	0.97	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	29.67	7.99	1.14	0.00	0.00	0.00	1.14	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	33.68	10.40	7.90	3.74	0.42	0.42	0.42	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	61.84	22.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	44.09	15.22	7.61	7.29	0.00	0.32	0.63	0.63	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	20.89	5.43	2.51	2.09	0.00	0.00	0.42	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	14.74	4.76	4.18	2.55	0.12	0.23	0.46	0.23	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	20.26	5.06	2.19	3.21	0.51	0.00	0.34	0.17	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	15.02	5.69	2.05	2.50	0.00	0.68	0.00	0.23	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	17.27	6.34	5.14	3.28	0.66	0.00	0.11	0.33	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	16.55	4.94	2.58	4.30	0.21	0.00	0.64	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	15.29	6.03	2.37	4.52	0.86	0.00	0.00	0.00	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	8.34	5.60	2.37	1.74	0.25	0.00	0.00	0.12	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	8.41	3.95	0.86	0.51	0.51	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	9.93	2.24	0.96	1.28	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	31.34	8.95	0.00	3.92	0.56	0.00	0.56	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	44.14	18.61	5.63	4.76	0.87	0.43	1.30	1.73	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	23.79	10.58	0.00	0.00	2.64	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	47.26	15.87	1.06	2.82	0.35	0.00	0.71	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	36.33	15.98	4.36	7.27	0.00	0.00	0.00	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	23.78	11.89	7.34	7.17	0.35	0.35	1.22	0.17	0.00
Hepatocyte, donor1	11523-119I2	13.32	16.95	4.84	3.63	0.00	0.00	0.00	1.21	0.00
Hepatocyte, donor2	11603-120I1	23.70	11.85	5.39	7.54	1.08	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	13.50	14.72	2.45	6.75	1.23	0.00	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	105.08	0.00	9.14	2.61	1.31	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	137.55	46.32	8.56	7.87	1.75	1.22	3.32	1.92	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	18.39	8.51	1.92	1.78	0.14	0.41	0.41	0.00	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	47.76	50.94	3.18	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	26.70	0.00	0.00	0.00	6.68	0.00	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	135.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	59.53	48.45	1.38	1.38	0.00	0.00	0.00	1.38	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	40.04	32.53	0.00	0.00	0.00	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	11.87	0.00	11.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	74.32	79.45	10.25	0.00	5.13	2.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	36.57	27.42	0.00	0.00	0.00	0.00	0.00	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	45.48	48.73	4.87	0.00	0.00	1.62	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	45.02	38.35	6.67	1.67	1.67	5.00	1.67	1.67	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	36.31	25.41	0.00	3.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	51.62	50.29	2.65	1.32	0.00	0.00	1.32	2.65	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	36.59	29.93	1.11	5.54	1.11	2.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	62.86	41.91	0.00	5.24	0.00	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	44.72	43.46	2.52	5.04	0.00	0.63	0.63	0.63	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	29.39	30.93	1.55	4.64	1.55	0.00	0.00	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	53.62	54.27	3.23	4.52	0.00	0.00	0.00	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	38.64	33.81	0.00	3.22	0.00	1.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	71.69	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	32.60	49.71	2.44	2.44	2.44	0.81	0.00	0.81	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	39.04	41.14	0.42	0.00	0.00	2.52	0.00	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	40.18	46.61	0.80	0.00	0.00	0.80	0.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	25.85	18.47	4.62	2.77	0.00	0.00	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	35.40	32.10	2.83	3.78	0.47	0.94	0.00	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	27.21	18.14	5.44	2.72	1.81	2.72	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	44.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	39.82	21.52	2.15	3.23	1.08	1.08	1.08	2.15	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	38.11	19.06	3.81	5.08	2.54	0.00	1.27	1.27	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	32.86	0.00	0.00	0.00	0.00	0.00	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	41.45	38.26	1.28	1.28	0.64	1.28	0.00	1.91	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	30.99	27.34	3.65	3.65	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	32.13	39.27	5.71	2.86	0.00	2.86	1.43	0.71	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	53.09	19.91	0.00	3.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	104.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	37.35	27.78	1.85	3.09	0.62	0.31	0.62	0.93	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	49.17	19.32	1.76	1.76	1.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	28.29	22.00	0.00	0.00	0.00	3.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	49.37	41.72	2.09	2.09	0.00	0.70	0.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	70.82	24.34	0.00	4.43	0.00	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	32.42	25.94	0.00	3.24	0.00	0.00	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	40.11	22.67	0.87	0.87	0.87	0.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	22.50	9.00	0.00	0.00	0.00	0.00	0.00	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	31.36	10.45	0.00	3.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	44.80	20.27	1.07	2.13	1.07	3.20	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	51.26	11.08	0.00	0.00	0.00	2.77	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	25.65	17.10	0.00	2.85	0.00	5.70	0.00	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	38.66	25.77	0.92	1.84	0.00	0.92	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	24.20	9.08	0.00	6.05	0.00	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	6.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	31.72	21.15	0.00	0.00	0.00	0.00	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	21.05	15.59	4.00	1.55	0.65	0.33	0.98	0.57	0.00
Keratinocyte - epidermal, donor2	11349-117G8	25.18	11.71	0.00	0.59	1.76	0.00	0.59	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	23.57	14.48	1.42	3.12	0.85	0.00	0.66	0.28	0.00
Keratinocyte - oral, donor1	11251-116E9	58.23	35.64	4.77	7.49	0.79	0.91	1.36	1.14	0.00
Keratocytes, donor1	11527-119I6	99.37	18.91	3.44	3.44	0.00	0.00	0.34	0.69	0.00
Keratocytes, donor2	11607-120I5	22.26	10.55	5.86	3.52	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	58.29	11.86	3.75	4.15	0.99	0.59	0.00	0.59	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	21.98	37.36	24.18	21.98	0.00	0.00	6.59	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	19.42	9.71	15.10	4.31	1.08	0.00	1.08	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	56.51	11.65	3.58	2.42	0.81	1.15	0.35	0.35	0.00
Lens Epithelial Cells, donor3	11690-122I7	19.78	8.98	0.81	0.61	0.20	0.20	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	14.11	16.84	2.13	2.37	0.71	0.36	0.36	0.71	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	17.58	27.07	14.79	7.26	1.12	0.28	0.00	0.84	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	17.32	16.69	9.13	4.56	1.26	0.31	0.31	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	13.98	15.59	2.69	8.60	1.61	0.00	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	16.39	30.89	12.29	4.73	1.58	0.63	0.63	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	14.45	15.85	5.93	5.61	0.65	0.32	0.22	0.65	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	19.70	28.73	12.31	10.26	0.00	0.00	0.82	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	23.26	56.13	17.70	12.39	0.51	1.01	1.77	1.01	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	22.10	35.33	15.20	9.43	1.13	0.42	0.42	1.13	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	14.63	37.58	14.63	11.07	0.40	0.00	0.40	0.79	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	21.33	57.20	18.81	12.60	2.13	1.16	1.16	0.19	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	22.22	45.73	19.26	10.92	0.56	0.56	0.93	1.11	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	11.85	47.04	14.63	16.03	1.05	0.35	1.05	1.05	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	21.71	57.48	19.56	10.73	0.72	0.72	1.19	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	21.56	48.90	17.99	11.40	0.82	0.27	0.96	0.69	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	15.40	30.80	12.93	13.24	1.23	0.62	0.62	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	18.39	47.39	19.95	11.22	0.94	1.25	0.62	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	22.87	39.89	16.84	9.88	0.55	0.18	0.91	2.20	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	11.52	30.28	9.87	9.22	1.65	0.33	1.32	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	17.87	44.81	19.92	8.20	1.46	0.88	0.88	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	17.18	24.15	13.19	4.48	1.00	0.25	0.75	0.75	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	13.09	28.61	10.18	10.67	0.97	0.00	0.97	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	14.27	32.85	12.39	8.35	0.54	0.27	0.81	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	11.05	14.08	7.11	3.94	1.06	0.30	0.15	0.45	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	9.33	15.03	8.29	9.33	1.04	0.52	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	19.26	41.67	15.08	8.38	1.68	0.21	1.05	0.63	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	8.57	16.09	6.62	4.66	1.05	0.00	1.05	0.45	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	14.45	17.20	6.88	6.88	1.38	0.00	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	15.62	30.10	11.67	5.64	0.75	0.56	0.56	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	16.43	16.33	4.88	4.98	0.00	0.64	0.74	0.32	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	18.90	15.51	10.18	5.33	1.45	0.00	0.97	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	17.86	34.40	7.61	6.95	0.99	0.00	0.66	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	18.46	21.68	9.29	4.46	0.50	0.25	0.62	0.99	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	11.85	11.48	7.03	3.33	0.74	0.37	0.00	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	18.78	24.21	12.60	5.44	0.49	0.25	1.24	0.49	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	16.64	16.36	9.21	3.99	1.79	0.69	0.27	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	14.47	13.51	5.47	8.68	0.64	0.00	0.32	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	23.43	30.13	11.56	4.56	1.52	0.30	0.91	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	13.30	17.08	7.42	4.34	0.42	0.00	0.70	0.70	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	11.38	12.80	7.82	10.67	0.71	0.00	0.36	0.00	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	16.97	28.60	13.57	6.79	0.97	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	17.12	17.58	10.74	5.91	0.31	0.16	0.62	1.09	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	12.89	13.25	7.88	13.25	0.36	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	21.23	29.07	10.45	5.23	0.98	0.65	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	13.18	13.89	9.65	4.47	0.00	1.88	1.18	0.47	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	15.35	14.85	1.49	1.73	1.36	0.12	0.37	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	18.70	33.55	8.71	3.59	1.54	0.51	0.77	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	14.62	14.92	4.77	4.77	0.30	0.00	0.30	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	58.92	24.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	43.73	23.78	4.60	3.84	1.53	0.00	0.77	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	32.66	17.07	0.00	2.23	0.74	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	54.58	38.50	5.50	7.62	0.42	0.00	1.69	1.69	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	53.45	30.95	8.44	9.14	2.11	0.00	1.41	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	45.76	23.35	0.93	4.67	3.74	0.00	0.93	1.87	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	51.01	30.92	8.76	11.85	4.12	1.55	0.52	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	47.58	32.12	4.76	2.38	4.76	0.00	0.00	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	48.18	38.68	1.58	1.36	0.68	0.23	0.45	0.68	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	43.91	31.41	11.92	17.74	3.78	0.87	0.58	1.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	45.47	32.41	6.75	8.10	3.60	0.00	0.90	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	73.84	62.59	3.66	2.17	0.95	0.95	1.22	1.08	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	60.60	28.24	12.32	6.68	3.08	1.54	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	37.76	31.76	6.35	7.41	3.18	1.06	1.06	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	41.31	28.65	1.33	5.33	2.00	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	71.82	43.30	12.73	12.73	5.09	1.02	0.00	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	55.76	39.22	7.74	12.54	4.54	0.53	0.53	0.80	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	54.98	44.02	13.23	9.64	2.46	0.76	1.32	1.70	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	79.15	48.47	12.27	14.11	4.91	0.61	1.23	2.45	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	75.83	53.00	8.15	11.42	2.45	0.82	0.82	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	62.26	44.77	22.91	10.20	4.79	1.04	0.83	2.92	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	55.49	35.87	16.82	15.13	5.89	0.56	1.96	1.40	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	70.06	64.91	5.15	8.24	4.12	0.00	1.03	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	71.12	42.96	21.77	11.61	6.10	0.58	0.87	1.45	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	50.22	26.31	12.56	7.17	2.69	0.30	1.79	1.79	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	53.11	30.98	3.87	12.72	0.55	1.11	1.11	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	80.95	55.85	13.08	9.19	3.89	0.00	1.06	1.77	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	54.58	30.24	10.69	8.85	4.43	0.37	1.11	2.58	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	65.62	26.48	4.61	3.45	1.15	1.15	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	75.98	43.36	13.43	5.37	3.07	0.38	3.07	1.92	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	60.58	30.57	5.10	9.62	3.96	0.00	2.26	2.26	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	39.38	22.15	2.46	4.10	1.64	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	61.91	38.41	15.36	6.78	1.81	0.45	2.26	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	58.89	24.42	4.31	5.75	5.03	0.00	0.72	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	59.01	24.65	2.99	2.99	1.49	0.00	0.75	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	75.43	37.16	9.66	4.83	5.57	1.49	1.49	1.86	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	53.41	20.68	7.75	4.31	3.88	0.43	0.86	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	54.80	25.69	3.43	1.71	1.71	0.86	0.86	1.71	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	57.97	38.65	9.33	5.33	5.00	0.33	1.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	57.31	21.12	6.03	7.84	1.81	0.00	0.00	1.81	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	49.77	24.88	2.13	3.55	2.13	0.71	2.84	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	73.21	36.09	15.81	7.91	4.81	0.34	1.72	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	53.67	28.45	6.44	6.98	3.76	0.00	1.61	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	56.56	24.24	4.71	7.41	1.35	1.35	1.35	2.02	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	75.56	47.41	20.74	8.15	3.70	0.37	0.74	2.22	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	67.45	19.77	0.00	1.16	1.16	0.00	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	58.18	27.50	1.06	5.29	1.06	0.00	0.00	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	69.23	46.42	15.21	10.40	4.40	0.40	4.40	1.60	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	58.15	49.43	2.18	3.63	2.91	1.45	0.00	1.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	78.95	55.96	3.83	3.07	2.30	0.00	3.07	1.53	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	62.65	46.37	9.37	1.97	2.47	0.49	1.48	0.99	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	67.75	33.87	2.82	2.82	4.70	0.94	2.82	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	75.93	56.32	4.53	3.02	2.01	0.00	1.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	78.41	49.57	13.07	3.15	3.15	0.00	0.45	1.35	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	60.24	32.70	5.16	5.16	1.72	0.00	0.00	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	64.13	52.55	9.35	8.91	4.01	1.34	0.45	1.34	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	79.38	55.53	12.12	8.21	3.13	0.39	0.39	1.17	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	50.14	38.92	7.26	5.28	1.32	1.32	1.98	1.98	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	69.54	52.41	8.30	8.82	1.04	1.56	1.04	2.08	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	85.76	56.01	11.38	5.69	4.38	1.31	0.88	3.94	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	68.77	49.76	9.50	10.06	5.59	0.00	0.00	1.68	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	76.40	59.18	11.92	9.27	2.65	2.21	1.77	3.53	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	81.77	66.73	15.43	9.64	5.40	1.16	0.39	1.54	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	83.55	53.17	9.11	13.17	4.56	0.00	2.53	2.53	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	87.47	77.86	14.42	12.50	2.40	3.84	3.36	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	90.24	85.07	20.27	10.73	6.76	2.39	2.39	3.58	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	97.83	69.27	13.37	13.98	8.51	1.22	4.25	3.04	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	74.70	51.19	8.30	14.53	4.15	0.69	2.08	2.77	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	106.02	91.20	30.78	9.50	4.94	1.14	2.66	4.18	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	109.48	69.72	13.43	16.01	7.75	1.03	5.16	4.13	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	100.98	43.54	6.65	13.30	5.44	1.21	1.21	1.81	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	106.80	82.39	23.45	6.02	4.12	1.90	2.22	2.22	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	115.68	74.63	11.19	8.53	3.20	1.60	3.20	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	98.27	40.80	4.02	10.92	5.17	0.57	2.87	2.30	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	115.70	78.16	23.65	14.40	9.26	0.51	2.57	2.06	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	106.81	57.30	11.32	7.07	5.66	0.71	4.24	2.83	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	97.04	43.70	3.97	8.51	7.38	0.57	3.97	1.70	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	97.77	55.33	15.39	7.49	5.41	0.42	1.66	1.66	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	126.07	46.98	8.61	7.05	5.48	1.57	1.57	3.92	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	71.82	26.31	2.92	5.43	2.92	0.42	2.09	2.92	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	105.47	59.94	13.47	6.50	4.65	0.46	4.18	1.86	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	80.29	41.48	8.70	8.03	2.01	1.34	3.35	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	79.66	37.96	1.60	6.42	3.74	0.53	1.07	2.14	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	103.85	58.19	6.87	8.49	4.85	0.81	3.64	1.21	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	75.26	39.46	5.51	4.59	3.67	0.92	2.75	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	88.02	24.90	2.67	7.11	3.56	1.78	1.78	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	88.90	43.88	10.26	7.41	2.28	0.00	3.42	3.42	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	94.33	39.11	7.67	0.00	3.83	0.77	0.00	3.83	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	67.30	31.74	0.55	12.04	3.28	0.55	0.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	96.22	49.44	8.91	5.35	4.45	0.45	1.34	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	89.94	57.71	2.86	1.04	2.34	1.04	2.34	2.08	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	72.94	26.52	3.32	9.28	2.65	0.00	4.64	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	89.38	41.57	2.08	20.79	4.16	2.08	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	17.55	10.03	2.51	2.96	0.23	0.23	0.91	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	22.75	11.93	2.02	2.02	0.00	0.00	0.37	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	20.58	17.96	1.44	3.80	0.26	0.39	1.05	0.26	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	7.43	7.43	2.12	0.00	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	16.32	8.71	0.16	0.95	0.63	0.16	0.32	0.16	0.00
Mallassez-derived cells, donor3	11930-125I4	13.90	8.76	0.56	1.53	0.28	0.14	0.83	0.14	0.00
Mammary Epithelial Cell, donor1	11273-116H4	30.79	9.86	4.09	1.00	0.50	0.00	0.40	0.30	0.00
Mammary Epithelial Cell, donor2	11350-117G9	30.69	10.13	1.45	1.45	0.58	0.29	0.58	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	19.21	13.72	0.75	1.00	0.25	0.00	0.25	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	33.90	22.37	16.95	0.00	2.03	1.36	0.00	1.36	1.36
Mast cell, donor1	11563-120D6	42.39	28.98	3.35	3.68	2.27	0.97	0.76	1.73	1.41
Mast cell, donor2	11565-120D8	179.49	282.91	9.81	11.89	7.43	16.34	2.38	8.62	32.99
Mast cell, donor3	11566-120D9	185.73	90.05	11.93	9.68	4.28	13.06	0.90	6.75	16.21
Mast cell, donor4	11567-120E1	78.89	194.84	6.74	5.32	1.60	11.35	1.77	6.21	13.65
Mast cell, expanded and stimulated, donor5	11940-126A5	32.82	18.52	1.33	2.66	1.66	1.00	0.44	1.11	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	46.11	22.76	2.33	1.75	3.50	0.58	0.00	4.09	2.33
Mast cell, expanded, donor5	11939-126A4	34.07	15.03	2.06	1.38	0.92	1.38	0.46	1.84	0.23
Mast cell, expanded, donor8	11941-126A6	26.28	30.63	2.01	1.67	1.00	1.00	0.67	2.18	2.18
Melanocyte - dark, donor1	11502-119F8	10.75	8.16	1.39	0.60	0.10	0.10	0.00	0.30	0.20
Melanocyte - dark, donor2	11582-120F7	41.88	12.46	6.58	6.23	0.35	0.00	1.04	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	22.09	10.65	1.45	1.52	0.43	0.65	0.65	0.14	0.00
Melanocyte - light, donor1	11274-116H5	30.79	10.58	0.71	0.47	0.00	0.47	0.47	1.18	0.00
Melanocyte - light, donor2	11351-117H1	17.74	8.87	0.00	0.68	0.68	0.00	0.00	2.05	0.00
Melanocyte - light, donor3	11423-118G1	38.16	11.27	1.73	1.73	0.00	0.00	2.60	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	21.76	10.72	1.77	2.19	0.62	0.42	0.42	0.42	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	16.94	7.80	4.84	1.08	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	21.70	3.21	2.14	3.21	0.54	0.54	0.54	0.27	0.00
Meningeal Cells, donor1	11493-119E8	50.24	10.30	1.12	0.12	0.12	0.37	1.24	0.12	0.12
Meningeal Cells, donor2	11573-120E7	37.41	11.88	0.44	0.88	0.88	0.44	0.44	1.76	0.00
Meningeal Cells, donor3	11654-122E7	44.83	12.06	2.93	2.28	0.24	0.65	0.33	0.16	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	49.05	19.39	5.13	4.56	0.57	0.29	1.14	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	9.16	7.45	1.21	0.81	0.30	0.10	0.10	0.10	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	80.16	21.03	0.00	0.00	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	15.70	7.85	3.92	2.62	0.00	2.62	0.00	2.62	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	25.83	12.20	2.87	0.72	0.72	0.00	0.00	2.87	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	23.08	8.89	2.96	2.96	1.91	0.00	0.21	0.64	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	16.08	6.53	1.01	6.03	1.01	0.00	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	44.39	16.26	1.54	2.42	0.44	0.22	1.76	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	41.64	13.88	3.65	9.50	0.73	0.73	0.73	3.65	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	39.90	17.80	4.91	3.48	0.20	0.20	1.64	0.20	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	36.84	10.25	0.42	1.25	0.55	0.00	0.28	0.28	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	59.10	13.38	2.60	2.97	0.74	0.00	0.74	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	46.31	14.47	3.55	1.58	0.66	0.13	0.26	0.39	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	41.54	14.54	2.97	1.48	0.00	0.59	1.19	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	42.04	18.68	7.01	0.00	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	18.57	3.20	1.92	3.20	0.00	1.28	0.64	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	19.14	21.98	4.25	1.77	0.35	1.42	1.06	1.06	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	42.22	16.26	3.13	2.81	0.00	0.31	0.31	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	20.32	10.16	2.90	4.35	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	20.68	11.93	2.92	1.06	0.00	0.53	0.27	0.53	0.00
Mesothelial Cells, donor2	12156-128G5	19.02	9.01	0.50	0.00	0.00	0.00	1.50	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	26.30	17.27	3.47	4.99	0.65	0.29	1.23	0.87	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	17.55	5.40	1.35	2.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	12.31	9.85	5.17	1.97	0.25	0.00	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	14.72	10.31	2.06	1.77	0.00	0.29	1.47	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	24.20	27.66	3.46	0.00	0.00	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	10.85	4.65	3.41	3.72	0.62	0.00	0.00	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	14.31	11.82	2.28	1.66	0.21	0.21	0.41	0.21	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	16.21	20.84	2.32	0.00	0.00	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	12.51	13.76	4.75	2.25	0.50	0.00	0.25	0.50	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	14.90	8.38	5.12	1.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	12.80	10.97	3.05	2.44	0.00	0.20	0.20	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	10.30	11.48	0.79	1.58	0.00	0.00	0.79	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	17.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	3.54	3.54	5.31	2.65	0.00	0.00	0.00	0.88	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	9.50	10.26	3.42	2.28	0.00	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	6.58	14.47	5.26	1.32	0.00	0.00	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	4.03	8.06	1.27	2.12	0.42	0.21	0.42	0.00	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	6.45	3.68	0.00	0.00	0.00	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	215.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	2.98	3.87	0.89	0.00	0.30	0.00	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	8.38	1.68	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	3.51	2.01	1.76	1.00	0.00	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	3.09	2.14	0.48	0.24	0.00	0.48	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	3.32	9.95	0.55	0.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	3.68	8.98	1.38	3.68	0.00	0.23	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	2.73	2.94	2.73	0.21	0.00	0.21	0.42	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	8.15	7.75	0.61	0.41	0.00	0.41	0.00	0.20	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	9.23	7.29	1.50	3.43	0.00	0.43	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	4.22	6.67	1.33	0.44	0.00	0.00	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	6.57	8.98	1.75	4.38	0.66	0.44	0.22	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	9.13	6.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	6.63	4.97	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	14.95	9.24	2.45	4.08	0.27	0.54	0.82	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	11.76	4.41	1.76	0.88	0.00	0.00	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	9.81	7.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	12.97	6.73	3.84	1.92	0.48	0.48	0.00	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	10.01	5.20	1.60	2.40	0.00	0.00	0.40	0.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	16.45	17.83	12.34	1.37	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	16.02	11.51	3.50	3.00	1.50	1.00	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	12.23	0.00	2.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	11.82	10.51	1.75	2.63	0.00	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	11.04	12.14	4.41	0.00	0.00	0.00	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	15.37	13.45	3.20	0.00	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	13.88	8.93	3.72	6.69	0.99	0.25	1.49	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	10.44	10.44	3.48	1.39	0.00	0.70	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	15.47	17.68	2.21	0.00	0.00	0.00	8.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	20.85	13.33	3.08	6.15	2.05	0.34	0.00	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	9.63	7.88	0.88	2.19	0.00	0.00	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	12.78	9.94	5.33	2.49	0.00	0.00	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	18.24	7.01	6.45	6.73	1.12	0.28	0.84	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	11.22	12.47	0.83	0.42	0.42	0.00	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	12.24	10.49	1.75	0.58	0.58	0.58	0.58	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	16.59	8.75	4.83	4.83	0.90	0.60	0.30	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	9.18	10.43	1.25	1.67	0.00	0.00	0.83	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	21.66	7.22	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	17.55	16.62	1.85	0.92	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	15.37	11.38	0.00	1.14	0.57	0.00	1.71	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	14.79	12.85	0.83	1.38	0.00	0.00	0.55	0.00	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	12.96	5.44	3.63	4.15	0.78	0.00	0.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	10.30	5.58	0.86	0.43	0.00	0.00	1.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	12.07	12.07	0.64	0.00	0.00	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	14.15	8.27	3.47	2.40	0.27	0.27	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	22.45	11.08	2.39	2.39	0.30	0.00	2.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	16.39	10.88	1.13	0.57	0.00	0.14	1.13	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	14.01	7.33	4.46	7.01	0.32	0.32	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	9.07	9.29	1.55	1.11	0.00	0.00	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	12.13	11.00	2.28	0.76	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	14.49	7.67	3.13	4.55	0.57	0.28	0.57	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	16.47	9.59	0.49	3.93	0.00	0.25	0.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	26.07	9.12	3.91	0.65	0.00	1.30	0.00	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	17.35	10.58	2.35	4.12	0.00	0.29	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	27.10	10.38	2.02	2.59	1.15	0.00	2.59	0.00	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	32.15	7.42	2.06	1.24	0.00	0.41	0.82	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	19.95	9.53	2.08	1.79	0.30	0.30	0.30	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	3.77	3.77	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	14.26	7.13	0.00	0.00	0.00	0.00	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	9.53	6.90	1.64	3.29	0.33	0.33	0.00	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	8.42	8.42	7.36	6.31	0.00	0.00	0.00	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	6.72	3.76	1.58	0.40	0.00	0.20	0.59	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	9.31	9.31	1.86	4.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	12.02	7.51	0.38	1.88	0.38	0.75	0.75	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	12.25	4.00	3.20	3.46	0.00	0.00	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	20.92	18.32	0.90	1.92	0.45	0.34	0.34	0.45	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	23.58	14.73	8.84	10.31	0.00	0.00	0.74	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	17.59	14.29	4.76	5.86	1.10	0.37	0.00	1.47	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	31.11	21.78	7.78	24.89	1.56	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	2.14	3.21	0.53	0.53	0.00	0.00	1.60	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	7.73	3.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	14.14	18.18	6.06	5.05	0.00	0.00	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	5.06	5.06	0.42	1.69	0.42	0.00	2.53	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	27.24	57.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.18	3.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	2.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	15.10	15.10	0.00	4.53	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	199.86	582.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	117.45	401.28	0.00	0.00	0.00	0.00	6.52	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	42.77	99.80	0.00	0.00	0.00	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	112.94	163.14	0.00	0.00	0.00	0.00	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	20.25	7.11	1.29	1.29	0.86	0.22	0.43	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	24.56	11.50	2.61	6.27	1.05	0.52	0.00	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	10.01	11.35	2.00	2.00	0.67	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	13.77	11.27	4.59	2.92	0.00	0.42	0.83	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	24.53	13.88	2.28	4.37	0.76	0.76	0.38	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	20.75	9.58	6.38	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	12.24	6.12	0.68	4.08	0.00	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	5.51	1.84	3.68	1.84	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	15.07	9.21	2.93	3.77	1.26	0.00	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	12.55	8.14	1.16	3.49	0.46	0.00	0.23	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	12.97	7.57	1.89	1.89	0.54	0.27	0.81	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	25.65	10.72	3.57	1.47	0.00	0.42	0.21	0.21	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	13.40	7.94	1.99	0.99	0.50	0.50	0.99	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	12.18	6.77	1.35	2.44	0.54	0.54	0.27	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	10.43	4.53	1.81	3.63	0.00	0.00	0.00	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	17.47	7.02	1.31	1.80	0.33	0.33	0.82	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	16.40	6.56	2.92	2.73	0.55	0.00	0.00	0.36	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	14.85	10.08	3.18	4.24	2.12	0.53	0.53	1.06	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	16.21	18.01	3.00	4.20	1.80	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	23.96	3.94	1.97	4.92	1.97	0.98	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	12.52	7.16	1.14	3.25	0.16	0.00	0.00	0.33	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	19.23	8.29	2.47	3.00	0.00	0.53	0.71	0.18	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	23.91	11.25	2.11	4.22	0.70	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	25.74	11.95	3.68	5.52	0.92	0.46	0.46	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	18.64	11.25	3.21	2.25	0.32	0.00	0.64	0.64	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	18.28	5.52	3.45	1.72	1.72	0.00	0.34	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	20.23	12.64	0.00	2.53	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	21.39	11.14	2.23	3.12	0.00	0.00	0.45	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	19.90	5.93	3.39	4.23	1.69	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	18.99	9.49	2.61	6.41	0.47	0.24	0.24	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	14.59	6.44	1.72	3.00	1.29	0.86	0.43	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	9.03	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	14.66	6.00	1.67	3.00	0.33	0.00	0.33	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	21.64	9.47	4.96	3.16	0.00	0.00	0.00	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	7.94	6.35	1.59	7.14	0.00	0.00	0.79	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	19.50	9.29	4.64	1.86	0.93	0.93	0.93	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	14.38	6.05	0.76	2.27	0.76	0.38	0.00	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	17.92	5.87	2.61	4.56	0.98	0.00	0.65	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	14.38	9.59	2.61	3.05	0.44	0.44	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	19.90	11.31	2.71	2.26	0.00	0.45	1.36	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	14.11	4.41	5.29	3.53	0.88	0.88	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	35.24	10.64	6.65	7.31	2.66	0.00	1.99	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	15.87	7.94	1.98	2.98	0.00	0.00	0.50	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	15.70	6.89	1.91	3.06	0.00	0.38	0.38	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	27.83	6.65	2.42	5.14	1.51	0.30	0.30	0.91	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	19.89	10.17	3.09	1.11	0.66	0.66	0.44	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	18.97	6.78	3.39	0.68	1.36	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	10.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	16.46	7.32	1.83	4.88	0.61	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	15.74	7.55	1.89	5.04	0.00	0.00	0.31	0.63	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	17.55	8.78	1.82	4.24	0.61	0.30	0.00	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	21.36	8.70	0.79	11.08	2.37	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	27.21	1.13	3.40	6.80	4.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	0.00	5.06	5.06	5.06	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	15.16	9.07	0.87	1.99	0.12	0.25	0.37	0.25	0.00
Myoblast, donor2	11322-117D8	30.11	18.99	7.86	4.99	0.38	0.19	0.38	0.38	0.00
Myoblast, donor3	11398-118D3	17.32	11.27	1.85	0.50	0.34	0.00	0.34	0.17	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	62.17	17.95	3.21	6.42	0.88	0.73	0.44	0.44	2.63
Natural Killer Cells, donor1	11230-116C6	378.25	32.29	19.68	17.53	2.15	2.46	0.00	1.23	18.76
Natural Killer Cells, donor2	11311-117C6	287.08	13.57	47.95	31.66	4.22	4.22	0.90	3.02	22.01
Natural Killer Cells, donor3	11387-118C1	268.90	30.74	13.62	39.57	4.79	2.94	0.37	4.05	15.09
Neural stem cells, donor1	11275-116H6	149.89	32.30	3.63	1.81	2.18	2.18	0.36	4.36	0.36
Neural stem cells, donor2	11352-117H2	184.86	19.26	0.00	0.00	0.00	5.78	1.93	0.00	1.93
Neurons, donor1	11494-119E9	199.13	30.72	11.38	11.38	4.55	2.28	2.28	1.14	1.14
Neurons, donor2	11574-120E8	167.32	17.39	8.59	6.60	1.10	3.96	0.88	1.54	0.66
Neurons, donor3	11655-122E8	98.66	26.31	25.49	31.24	4.93	2.47	1.64	4.93	0.00
Neutrophils, donor1	11233-116C9	1193.41	400.90	92.80	73.31	40.83	32.48	0.93	40.83	42.69
Neutrophils, donor2	11314-117C9	1008.81	292.79	208.72	150.74	49.28	43.48	0.00	69.57	17.39
Neutrophils, donor3	11390-118C4	1568.03	428.81	32.99	33.60	37.87	42.15	4.28	57.42	80.63
Nucleus Pulposus Cell, donor1	11252-116F1	121.59	37.16	6.29	8.67	1.54	0.47	1.19	0.95	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	50.79	14.00	7.49	10.42	0.98	0.33	1.63	1.63	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	48.13	11.23	3.81	9.02	2.41	0.20	0.80	0.80	0.20
Olfactory epithelial cells, donor1	11933-125I7	18.31	6.19	6.06	8.12	1.38	0.00	0.69	0.41	0.00
Olfactory epithelial cells, donor2	11934-125I8	21.57	20.26	12.01	13.03	1.88	0.14	0.00	0.58	0.00
Olfactory epithelial cells, donor3	11935-125I9	15.66	10.56	6.13	7.15	1.02	0.11	0.45	0.11	0.00
Olfactory epithelial cells, donor4	11936-126A1	32.24	12.66	5.55	6.04	0.58	0.29	0.58	0.29	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	42.13	24.67	1.20	3.01	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	18.93	7.23	0.64	0.85	0.21	0.00	0.85	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	16.00	8.00	2.29	1.14	1.14	0.00	0.00	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	20.48	11.79	1.24	1.86	0.00	0.00	0.62	1.24	0.00
Osteoblast, donor1	11277-116H8	38.11	20.13	3.13	0.98	0.59	0.39	0.59	0.39	0.00
Osteoblast, donor2	11354-117H4	47.76	11.24	1.40	2.81	2.11	0.00	0.70	0.70	0.00
Osteoblast, donor3	11426-118G4	26.66	21.86	1.07	1.96	0.36	0.53	0.71	1.24	0.00
Pancreatic stromal cells, donor1	11249-116E7	26.87	12.21	2.44	3.29	0.42	0.25	0.08	0.84	0.00
Pericytes, donor1	11491-119E6	50.96	7.23	1.22	0.89	1.11	0.22	1.00	0.33	0.11
Pericytes, donor2	11571-120E5	47.54	7.70	1.13	3.85	0.91	0.91	0.45	0.91	0.00
Pericytes, donor3	11652-122E5	34.79	17.90	3.05	2.44	0.20	0.20	1.02	1.22	0.00
Perineurial Cells, donor1	11499-119F5	35.94	14.69	3.62	3.96	0.23	0.57	1.02	0.23	0.00
Perineurial Cells, donor2	11579-120F4	43.43	14.81	1.20	1.38	0.64	0.18	0.74	0.46	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	197.94	40.80	7.33	6.06	1.59	3.51	0.00	0.96	3.82
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	206.17	75.17	39.18	28.16	4.65	6.61	0.00	4.90	10.53
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	260.13	67.43	4.92	18.38	2.20	6.08	0.26	4.53	22.39
Placental Epithelial Cells, donor1	11278-116H9	15.31	31.81	3.35	0.96	1.20	0.48	0.00	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	21.07	14.42	0.00	0.00	0.00	1.11	0.00	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	24.34	21.20	1.57	1.18	0.39	0.59	0.79	0.59	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	12.97	7.59	1.58	5.70	1.58	0.32	0.32	2.53	0.00
Preadipocyte - breast, donor1	11467-119B9	15.57	5.06	3.00	0.75	0.94	0.00	0.19	0.75	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	25.19	15.14	2.09	1.04	0.65	0.13	0.13	0.26	0.13
Preadipocyte - breast, donor2	11328-117E5	18.01	7.88	2.25	1.58	0.45	0.00	0.68	0.68	0.00
Preadipocyte - omental, donor1	11468-119C1	23.34	11.08	2.66	1.49	0.32	0.21	0.21	0.75	0.00
Preadipocyte - omental, donor2	11329-117E6	19.20	8.29	1.31	1.75	0.00	0.00	0.44	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	26.64	16.62	1.43	8.17	1.15	0.43	1.58	1.86	0.00
Preadipocyte - perirenal, donor1	11469-119C2	28.54	6.89	2.95	1.97	0.00	0.00	3.94	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	31.33	16.58	1.84	0.61	0.00	1.23	0.00	0.61	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	24.44	13.10	6.73	4.78	1.59	0.53	0.18	0.71	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	19.75	11.92	1.02	1.87	1.02	0.17	0.00	0.17	0.00
Preadipocyte - visceral, donor1	11280-116I2	31.67	17.42	4.75	2.79	1.21	0.28	0.09	0.47	0.00
Preadipocyte - visceral, donor2	11357-117H7	33.13	10.58	4.14	3.22	1.84	0.00	0.46	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	20.17	12.02	3.13	4.70	0.63	0.10	0.31	0.42	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	165.94	54.31	8.75	11.31	7.84	0.75	3.77	7.09	0.00
Prostate Epithelial Cells, donor2	11331-117E8	35.75	18.96	7.72	4.87	2.84	0.14	1.76	0.68	0.14
Prostate Epithelial Cells, donor3	11404-118D9	63.87	43.48	4.23	15.55	4.10	0.55	8.82	3.37	0.06
Prostate Stromal Cells, donor1	11254-116F3	43.62	13.78	2.96	4.56	1.37	0.34	1.03	0.91	0.00
Prostate Stromal Cells, donor2	11332-117E9	32.81	11.12	9.32	5.74	0.90	0.18	0.18	0.54	0.00
Prostate Stromal Cells, donor3	11405-118E1	31.91	12.20	1.46	5.63	1.56	0.52	0.73	1.25	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	64.60	17.15	2.92	2.55	1.09	0.73	1.82	1.09	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	47.69	24.67	3.95	3.26	0.76	0.55	0.97	0.49	0.07
Renal Epithelial Cells, donor1	11517-119H5	82.68	37.03	4.06	2.03	0.51	0.51	1.52	2.03	0.00
Renal Epithelial Cells, donor2	11597-120H4	75.40	29.16	11.38	8.54	0.00	0.71	0.71	1.42	0.00
Renal Epithelial Cells, donor3	11678-122H4	59.18	24.35	5.50	4.13	0.85	0.95	1.48	0.85	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	17.02	10.21	0.00	2.04	0.68	0.00	1.36	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	10.38	10.51	0.54	2.16	0.27	0.13	0.54	0.54	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	33.30	19.09	7.55	6.22	2.66	0.67	0.22	0.89	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	35.27	24.62	1.33	3.33	0.00	0.00	1.33	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	66.25	22.67	2.42	3.96	0.66	0.22	0.88	1.54	0.00
Renal Mesangial Cells, donor2	11598-120H5	66.46	22.57	4.39	11.29	1.25	1.25	0.00	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	80.45	28.85	7.49	4.16	0.28	0.83	1.39	0.83	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	36.51	16.91	4.03	2.42	0.54	0.27	2.15	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	26.99	15.18	5.90	9.70	0.42	0.84	0.84	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	68.85	26.81	7.71	4.24	0.19	1.54	0.58	0.39	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	39.41	26.97	6.22	5.19	0.52	1.04	0.52	0.78	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	50.60	17.62	1.71	3.13	0.00	0.28	0.85	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	31.90	21.61	5.15	5.15	1.03	1.03	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	36.38	6.27	2.01	2.26	1.00	0.50	0.50	0.25	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	31.54	29.40	4.01	2.00	0.80	1.20	2.14	1.34	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	16.97	8.93	0.89	0.89	1.79	0.00	1.79	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	12.66	6.60	2.20	6.05	2.75	0.00	0.55	1.65	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	11.60	8.12	0.58	0.58	1.16	1.16	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	17.94	7.93	0.39	1.17	0.65	0.91	0.13	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	25.52	20.66	8.04	3.97	0.40	1.49	0.30	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	17.85	16.06	2.12	1.45	0.22	1.12	0.33	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	23.57	15.63	1.74	2.23	0.62	0.99	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	23.54	20.40	7.81	5.36	1.05	1.63	0.58	0.35	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	27.27	22.42	3.70	2.54	0.92	0.46	1.39	0.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	20.40	12.87	0.55	0.96	0.41	1.23	0.68	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	24.51	18.15	7.87	3.93	1.36	0.91	0.91	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	20.61	15.77	1.97	0.90	0.00	0.72	0.36	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	14.20	15.06	1.00	1.72	0.72	0.72	1.15	0.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	21.14	18.99	6.01	5.15	0.86	1.29	0.54	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	17.26	16.15	4.87	3.76	0.66	1.77	0.22	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	17.40	13.76	0.38	2.10	0.38	1.15	0.19	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	19.94	20.78	4.94	4.19	0.56	1.49	0.56	0.19	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	19.35	17.29	1.13	1.32	0.38	1.69	0.75	0.75	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	18.31	15.66	1.33	1.73	0.27	0.40	0.40	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	17.52	19.57	3.31	3.02	0.29	1.65	0.68	0.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	19.86	22.72	4.58	4.77	1.91	1.91	0.19	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	23.92	13.56	1.07	1.17	0.53	0.43	0.43	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	23.27	21.58	5.61	1.68	0.84	0.84	0.28	0.84	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	23.75	18.29	3.93	1.03	0.85	1.20	0.51	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	25.34	16.05	0.73	1.09	0.73	0.36	0.18	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	23.18	26.12	5.40	4.05	0.86	2.33	0.37	0.25	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	24.45	27.13	3.76	2.42	1.34	2.01	0.40	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	32.08	13.44	1.18	1.89	0.71	0.71	0.47	0.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	20.63	25.99	5.95	5.75	0.40	1.98	0.60	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	30.63	21.28	5.61	3.98	1.17	1.17	0.23	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	25.50	15.97	1.04	2.07	1.45	0.41	2.07	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	25.44	21.68	4.20	2.65	1.99	0.88	0.44	0.88	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	26.74	19.22	5.64	4.39	0.00	0.00	0.63	0.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	32.03	15.48	1.48	2.56	0.40	0.27	0.81	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	30.48	17.37	5.45	4.60	0.34	1.19	0.34	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	21.59	18.70	4.63	4.63	0.96	0.58	0.77	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	26.48	13.58	0.86	2.41	1.03	0.34	0.34	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	27.57	20.03	5.62	3.29	0.55	1.10	0.69	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	30.86	11.66	4.10	4.43	0.99	0.82	0.49	0.16	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	34.77	10.74	0.85	3.07	0.85	0.85	0.85	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	34.47	19.38	2.07	4.59	0.30	1.78	0.44	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	25.32	13.86	2.40	2.93	0.00	0.80	0.53	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	19.77	10.78	1.11	1.24	0.97	0.97	1.11	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	28.81	14.76	4.76	5.00	1.19	1.67	0.24	0.95	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	34.06	15.32	2.02	1.21	0.20	0.81	0.60	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	22.04	8.29	1.04	1.32	1.79	0.66	0.47	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	29.70	18.17	7.69	2.45	1.40	1.75	1.05	1.75	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	17.23	17.83	2.42	3.63	0.30	0.30	0.30	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	23.25	12.36	0.37	1.35	1.35	0.49	0.00	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	33.48	36.39	2.62	1.75	0.58	2.62	1.31	0.29	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	24.95	23.12	1.22	3.04	0.00	0.61	1.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	20.50	8.74	0.60	1.51	1.21	0.30	0.60	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	36.42	30.99	6.11	2.94	2.94	0.68	1.81	2.26	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	32.05	21.57	3.00	3.89	0.90	0.90	1.50	1.80	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	24.56	15.59	1.18	1.42	3.07	0.47	0.59	1.77	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	32.23	25.19	4.48	1.28	0.85	1.28	1.71	2.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	28.85	23.44	4.81	0.60	1.20	1.20	0.00	1.20	0.00
Schwann Cells, donor1	11498-119F4	46.45	8.46	0.38	5.83	0.94	0.19	0.56	0.56	0.00
Schwann Cells, donor2	11578-120F3	37.43	3.40	6.80	10.21	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	35.93	11.39	9.42	7.67	1.53	0.00	0.44	0.44	0.00
Sebocyte, donor1	11220-116B5	62.45	55.32	2.19	0.00	0.00	0.00	3.83	1.64	0.00
Sebocyte, donor2	11301-117B5	38.14	24.82	2.30	1.84	1.38	0.00	2.76	0.46	0.46
Sebocyte, donor3	11378-118B1	32.57	22.26	2.47	5.15	0.41	0.41	3.71	0.62	0.00
Sertoli Cells, donor1	11255-116F4	34.79	36.45	3.31	6.63	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	42.37	14.12	5.65	5.65	2.82	0.00	0.00	11.30	0.00
Skeletal Muscle Cells, donor1	11281-116I3	46.89	17.60	6.07	2.99	1.85	0.35	1.14	0.53	0.00
Skeletal Muscle Cells, donor2	11358-117H8	17.35	10.84	1.45	1.45	0.72	0.72	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	65.21	21.74	2.51	0.84	0.84	0.00	0.84	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	29.06	11.47	4.40	6.76	0.63	0.00	1.10	0.31	0.00
Skeletal Muscle Cells, donor5	11455-119A6	30.47	15.31	2.82	5.05	1.04	0.15	0.45	0.45	0.00
Skeletal Muscle Cells, donor6	11459-119B1	23.85	15.54	2.15	4.16	0.77	0.00	0.15	0.62	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	35.79	13.10	2.39	3.53	0.38	0.50	0.00	0.13	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	31.82	14.41	5.56	3.14	1.43	0.29	0.43	1.43	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	31.75	14.39	2.28	3.37	0.60	0.69	1.19	0.69	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	38.76	14.32	4.30	2.11	0.76	0.51	0.42	0.84	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	32.57	13.03	4.34	1.45	0.00	0.72	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	24.77	11.83	2.20	3.99	0.55	0.28	0.55	1.10	0.14
Skin - palm, donor1	10286-104F7	67.15	42.98	16.12	0.00	5.37	0.00	0.00	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	22.06	34.02	3.03	6.49	1.87	0.43	2.88	1.01	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	53.16	56.43	0.82	11.45	9.00	0.00	4.91	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	14.41	26.35	3.38	7.01	2.86	0.13	1.56	1.17	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	32.81	19.46	2.92	4.45	1.81	0.14	1.25	1.67	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	35.87	36.01	9.28	5.49	0.28	0.28	3.38	1.41	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	42.71	80.77	4.23	3.17	1.90	0.00	1.48	0.63	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	50.37	47.14	4.35	6.97	0.97	0.37	4.65	1.27	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	25.92	8.95	0.62	2.78	1.23	0.62	0.93	0.93	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	20.01	8.23	0.89	1.33	0.89	0.00	0.67	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	21.75	18.81	0.59	0.59	0.00	0.00	1.76	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	22.10	10.83	1.99	0.22	0.00	0.00	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	21.66	12.60	1.58	0.79	0.39	0.39	0.39	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	28.58	12.36	2.32	0.00	0.00	0.00	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	61.05	14.01	11.01	5.00	1.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	16.24	11.44	2.40	0.53	0.27	0.00	0.40	0.53	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	30.59	17.07	7.31	8.87	1.99	0.00	0.66	0.89	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	9.22	4.23	0.26	0.00	0.00	0.26	0.13	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	19.21	6.84	2.93	1.95	0.33	0.33	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	24.51	8.27	1.77	0.89	0.30	0.00	0.30	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	22.35	11.96	0.71	1.99	0.71	0.00	0.28	0.28	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	31.07	11.88	1.30	1.14	0.65	0.49	0.65	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	41.40	12.79	3.96	1.52	0.61	0.30	0.00	0.61	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	36.12	20.46	0.76	0.00	0.51	0.51	0.00	0.51	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	18.36	0.00	0.00	0.00	0.00	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	16.21	10.01	1.43	0.48	0.48	0.00	0.00	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	19.91	9.59	3.39	1.18	0.00	0.15	0.00	0.15	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	20.88	10.33	4.30	2.58	0.43	0.22	0.22	0.86	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	28.76	15.95	1.15	3.88	0.42	0.10	0.31	0.52	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	26.91	13.30	1.39	1.08	0.46	0.15	0.31	1.08	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	17.25	14.01	4.31	2.16	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	11.95	11.95	2.09	1.49	0.00	0.00	1.49	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	52.23	15.02	1.37	1.37	0.34	1.02	1.02	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	44.21	10.76	2.83	1.73	0.47	0.16	0.31	0.08	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	36.13	26.07	4.83	2.21	1.81	0.30	1.81	3.72	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	23.44	16.16	6.60	3.64	0.46	0.23	1.59	0.68	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	17.51	10.26	0.00	1.21	0.60	0.00	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	42.65	20.93	3.97	3.44	0.26	0.00	0.53	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	27.70	7.72	0.80	3.33	0.80	0.40	0.27	0.67	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	50.09	17.28	5.76	5.26	1.75	0.50	1.13	1.63	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	24.35	8.62	1.52	1.27	0.00	0.25	0.00	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	28.95	13.87	2.41	1.06	0.45	0.00	1.06	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	38.26	12.00	2.25	1.50	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	16.80	10.34	2.58	2.58	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	31.16	19.53	2.79	0.93	0.00	0.47	0.00	0.93	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	19.19	10.60	5.55	4.54	1.01	0.00	0.50	0.00	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	21.31	12.22	2.19	2.51	0.63	0.00	0.63	0.94	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	25.37	10.91	1.47	1.77	0.00	0.00	0.29	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	26.74	11.25	1.50	1.25	0.25	0.08	0.42	0.08	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	27.56	12.15	4.20	6.54	1.87	0.00	0.47	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	15.54	12.52	1.30	0.29	0.29	0.43	1.01	0.14	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	22.18	15.81	0.76	3.31	0.51	0.00	0.76	0.51	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	16.36	8.09	1.32	0.94	0.38	0.38	0.38	0.38	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	25.57	10.62	1.96	3.07	0.14	0.42	0.14	0.28	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	25.30	12.99	2.35	2.09	0.17	0.25	0.17	0.17	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	29.52	9.05	0.95	1.90	0.00	0.95	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	16.39	12.97	1.22	1.22	0.00	0.24	0.24	0.00	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	20.77	7.95	1.99	2.65	1.33	0.00	0.66	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	14.63	5.27	1.17	0.88	0.29	0.29	0.29	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	31.29	11.66	2.33	5.83	1.17	0.00	0.39	0.58	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	14.02	5.82	0.79	5.82	0.79	0.00	0.53	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	19.34	6.32	1.12	13.39	3.35	0.00	0.37	1.12	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	23.36	9.70	2.87	5.75	0.72	0.00	0.00	0.36	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	22.14	8.52	2.56	4.54	0.28	0.28	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	21.66	9.45	1.18	9.85	0.39	0.00	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	25.65	10.67	3.05	7.87	1.27	0.00	0.00	1.02	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	35.54	18.77	2.40	9.58	3.59	0.00	0.40	1.20	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	22.57	7.52	4.60	9.61	2.09	0.00	0.00	0.84	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	33.00	11.00	5.50	11.00	0.00	0.00	0.00	0.46	0.00
Synoviocyte, donor1	11291-117A4	30.47	30.80	8.08	3.03	0.50	0.34	4.04	1.51	0.00
Synoviocyte, donor2	11368-117I9	31.85	22.96	4.53	10.39	1.51	0.00	0.17	0.67	0.00
Synoviocyte, donor3	11440-118H9	23.01	12.06	2.68	4.02	1.56	0.00	0.22	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	58.24	23.94	0.71	1.79	0.36	1.43	1.79	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	27.75	11.89	1.98	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	49.78	12.04	3.47	2.08	0.00	0.46	0.69	0.46	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	25.30	19.93	5.73	2.01	0.65	0.29	0.86	0.65	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	20.49	22.03	0.39	3.87	0.39	0.00	1.16	0.77	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	24.05	21.19	0.57	0.00	0.00	0.00	1.15	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	34.69	34.94	5.17	1.85	1.60	0.49	1.11	0.74	0.25
Urethra, donor2	10319-105A4	48.56	30.57	10.79	0.00	3.60	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	37.19	18.60	2.13	2.92	0.27	0.80	1.06	0.53	0.00
Urothelial Cells, donor2	11600-120H7	29.24	10.41	5.61	8.01	0.00	0.40	1.20	0.00	0.00
Urothelial Cells, donor3	11681-122H7	37.82	20.63	4.35	1.83	0.46	0.69	1.83	0.46	0.00
Urothelial cells, donor0	11216-116B1	35.66	22.51	5.13	4.24	0.45	0.22	1.56	0.45	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	195.75	39.15	1.78	2.67	1.78	0.89	2.67	2.67	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	167.26	38.60	1.43	8.58	0.00	1.43	0.00	2.86	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	167.71	30.12	23.96	10.95	1.37	1.37	2.74	2.05	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	130.50	15.50	8.61	6.89	0.69	1.03	1.03	0.34	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	152.81	29.05	12.78	2.32	1.74	1.16	2.32	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	233.24	49.98	3.12	4.16	2.08	1.04	1.04	1.04	5.21
Whole blood (ribopure), donor090612, donation2	12183-129A5	155.11	30.29	3.67	4.59	1.84	1.84	0.00	3.67	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	153.37	26.47	26.47	13.69	0.91	0.91	0.00	1.83	0.91
Wilms' tumor cell line:G-401	10809-111A8	26.52	19.61	1.85	3.21	1.36	1.60	0.25	0.86	0.12
Wilms' tumor cell line:HFWT	10597-108E3	26.40	11.44	4.40	0.88	0.88	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	50.56	59.49	17.32	12.01	1.68	1.68	0.56	1.40	0.56
achilles tendon, donor2	10292-104G4	53.73	31.00	10.33	6.20	0.00	0.00	0.00	0.00	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	43.34	5.61	7.65	7.90	1.02	0.25	0.51	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	48.99	2.09	3.48	3.48	0.70	0.46	0.70	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	102.09	5.22	5.82	2.73	0.47	1.66	0.24	0.47	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	59.87	1.90	6.80	4.35	1.63	0.00	0.54	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	17.15	1.41	0.84	1.41	0.00	0.84	0.00	0.28	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	49.91	13.96	1.06	0.21	0.00	1.27	0.00	0.63	1.27
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	76.76	26.68	12.25	10.07	2.99	0.82	0.00	1.36	5.99
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	25.56	7.05	0.44	0.44	0.00	0.44	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	46.96	14.70	3.68	2.45	0.41	1.63	0.00	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	65.23	27.18	6.21	16.31	1.55	1.94	0.78	1.16	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	34.04	3.68	2.58	2.58	0.18	0.18	0.00	0.18	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	27.30	11.70	0.00	3.90	0.00	0.00	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	39.27	16.96	3.72	4.18	0.70	0.46	1.16	0.23	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	70.16	9.32	6.21	4.92	1.29	1.81	0.78	0.52	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	43.84	7.89	3.51	6.43	1.75	0.58	0.00	0.58	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	34.39	9.30	3.72	0.46	1.39	0.46	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	53.05	15.22	4.11	2.47	0.41	0.41	0.00	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	33.46	7.98	0.61	5.53	1.53	0.31	0.61	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	31.15	10.67	0.43	0.85	0.85	0.43	0.00	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	24.57	8.49	1.52	1.52	0.61	0.61	0.30	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	27.44	8.67	0.72	1.68	0.24	0.48	0.24	0.48	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	16.93	4.23	1.56	0.89	0.89	0.00	0.00	0.67	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	44.36	13.68	7.34	1.00	0.00	0.33	0.33	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	26.01	1.86	5.57	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	21.09	7.16	1.51	0.38	1.13	1.13	0.00	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	52.34	8.29	3.49	2.18	0.00	2.18	0.44	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	33.74	15.00	15.00	11.25	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	24.26	37.68	4.00	4.00	0.47	0.94	1.41	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	48.09	41.11	3.72	1.09	1.71	1.09	0.47	1.40	1.71
adipose, donor1	10184-103D4	99.10	15.25	12.31	24.04	19.35	8.21	0.00	2.93	0.00
adipose, donor2	10185-103D5	192.62	27.58	24.33	49.47	11.35	6.49	3.65	3.24	0.00
adipose, donor3	10186-103D6	116.81	31.04	11.98	32.40	5.45	2.45	1.36	3.00	0.00
adipose, donor4	10187-103D7	121.35	16.47	27.74	27.74	5.20	6.07	0.00	4.33	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	27.93	24.78	2.53	2.68	0.16	1.58	0.79	0.79	0.00
adrenal gland, adult, pool1	10081-102A9	14.55	47.29	0.00	7.28	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	41.76	18.68	3.87	2.40	1.20	3.34	1.07	0.27	1.47
alveolar cell carcinoma cell line:SW 1573	10708-109H6	30.37	14.65	8.22	5.72	1.43	0.36	0.36	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	24.11	102.94	7.88	5.56	1.85	0.70	2.78	1.39	0.00
amniotic membrane cells, donor2	12236-129G4	17.92	9.47	3.38	1.01	0.68	1.01	0.00	0.68	1.01
amniotic membrane cells, donor3	12237-129G5	33.29	61.57	5.30	4.71	0.59	0.59	3.24	1.18	0.00
amygdala - adult, donor10196	10167-103B5	40.32	23.72	3.56	11.86	1.19	1.19	2.37	1.19	0.00
amygdala, adult, donor10252	10151-102I7	29.00	17.44	2.03	1.62	0.81	1.42	0.81	1.42	0.00
amygdala, newborn, donor10223	10360-105E9	53.58	34.21	2.58	10.01	2.26	0.32	1.94	0.65	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	47.88	14.26	3.82	1.15	0.51	0.25	0.38	0.76	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	54.05	56.26	8.38	20.52	1.99	2.65	2.43	1.10	8.60
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	124.26	25.05	7.01	10.02	1.34	3.01	1.00	0.33	0.00
aorta, adult, pool1	10052-101G7	52.37	41.58	4.51	5.69	1.96	1.37	0.59	0.98	0.20
appendix, adult	10189-103D9	70.25	39.20	11.64	5.82	0.78	1.55	1.16	1.94	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	14.45	3.78	1.72	2.75	0.34	0.34	0.34	0.00	0.00
artery, adult	10190-103E1	31.25	92.39	27.17	5.43	13.59	1.36	1.36	4.08	1.36
astrocytoma cell line:TM-31	10425-106D2	37.23	19.41	3.77	3.48	0.14	0.43	1.30	0.72	0.00
b cell line:RPMI1788	10427-106D4	26.32	20.67	1.78	0.89	0.59	2.08	0.30	0.30	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	13.04	7.77	1.94	1.11	0.00	0.28	0.28	0.55	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	28.88	23.91	2.78	1.39	0.20	0.20	0.69	0.20	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	41.84	27.28	8.37	4.85	1.00	0.33	1.67	0.33	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	52.57	12.86	7.27	8.95	0.00	1.68	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	41.18	26.29	2.72	2.50	0.87	0.98	0.65	0.87	0.22
blood, adult, pool1	10053-101G8	148.38	24.36	8.86	19.93	0.00	2.21	0.00	2.21	6.64
bone marrow stromal cell line:StromaNKtert	10686-109F2	28.26	11.99	3.43	4.28	0.00	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	24.29	6.75	4.05	0.67	5.40	0.67	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	22.55	10.25	4.10	1.03	1.03	3.08	3.08	1.03	0.00
brain, adult, pool1	10012-101C3	55.46	25.61	6.35	2.67	0.78	2.12	0.89	1.22	0.56
brain, fetal, pool1	10085-102B4	77.47	26.71	2.67	5.34	0.00	2.67	5.34	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	37.99	27.09	9.25	7.60	0.33	0.33	0.33	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	103.10	81.51	7.74	6.37	0.25	1.50	2.00	0.62	0.25
breast, adult, donor1	10080-102A8	32.20	11.36	2.53	2.53	0.63	0.63	0.00	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	20.20	33.54	4.57	10.04	0.76	0.25	2.79	0.38	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	18.86	52.88	11.44	9.90	0.62	0.62	1.24	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	6.22	12.66	2.76	4.14	0.69	0.00	0.00	0.92	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	31.71	16.46	6.78	4.84	0.24	0.24	0.00	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	14.11	6.11	5.64	2.82	0.47	0.94	0.47	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	52.17	64.97	3.72	3.39	0.22	1.31	2.52	0.44	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	32.01	2.22	8.24	5.70	0.00	0.63	0.32	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	39.39	13.58	3.19	3.19	0.00	1.33	0.27	0.80	0.00
caudate nucleus - adult, donor10196	10177-103C6	42.60	42.60	2.30	1.15	1.15	1.15	2.30	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	32.96	16.90	1.67	1.84	0.33	0.50	1.17	0.17	0.00
caudate nucleus, adult, donor10258	10379-105H1	13.75	9.17	0.00	4.58	0.00	0.76	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	64.09	22.34	2.56	14.28	2.20	1.10	0.00	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	40.79	26.22	0.00	0.00	0.00	0.00	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	23.27	20.07	2.78	1.28	0.43	1.49	2.78	1.07	0.21
cerebellum, adult, pool1	10083-102B2	17.59	7.24	2.76	4.14	1.03	0.34	0.00	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	48.99	24.91	1.66	4.98	4.98	2.49	0.00	0.83	0.83
cerebral meninges, adult	10188-103D8	41.86	33.28	8.07	5.29	1.01	1.26	0.50	0.50	0.25
cerebrospinal fluid, donor2	10294-104G6	10.96	14.62	8.04	5.12	2.19	0.00	0.00	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	34.08	9.06	1.73	2.44	0.58	0.00	0.29	0.58	0.00
cervical cancer cell line:ME-180	10553-107I4	36.79	63.30	6.30	5.80	0.33	0.99	1.16	0.66	0.00
cervix, adult, pool1	10013-101C4	49.45	39.37	5.77	3.46	0.52	1.78	0.94	2.41	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	70.37	18.39	6.13	4.74	0.98	0.42	0.42	0.70	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	24.82	18.29	6.53	1.31	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	45.49	14.17	4.47	3.48	1.49	0.75	0.87	1.37	0.00
choriocarcinoma cell line:SCH	10785-110H2	44.48	23.41	6.65	11.34	1.85	0.25	2.22	0.49	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	13.99	17.08	5.22	5.46	0.95	0.47	1.19	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	16.81	91.17	11.68	5.70	0.85	0.85	3.99	1.42	0.28
chorionic membrane cells, donor2	12239-129G7	33.71	18.99	2.68	2.88	0.89	0.20	1.59	0.89	0.00
chorionic membrane cells, donor3	12240-129G8	28.57	34.07	4.95	4.40	2.20	0.55	2.75	1.65	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	31.30	1.01	3.03	5.05	1.01	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	28.62	15.18	2.69	3.27	0.58	1.54	0.00	0.19	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	12.25	5.28	1.69	2.32	0.21	0.00	0.21	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	41.60	20.80	4.37	2.57	0.26	1.54	0.00	0.77	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	43.54	21.04	4.35	2.42	0.97	1.94	0.24	0.00	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	50.50	21.38	3.26	3.66	0.20	0.61	0.20	0.41	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	25.91	18.26	8.83	4.42	0.59	2.36	0.00	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	52.13	22.94	2.61	2.35	0.52	0.52	0.26	0.52	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	29.26	15.77	3.66	5.49	1.14	0.69	0.69	0.91	0.00
clear cell carcinoma cell line:TEN	10636-108I6	38.69	30.02	6.25	4.68	2.08	1.39	0.35	0.87	0.00
colon carcinoma cell line:CACO-2	10513-107D9	49.79	16.11	5.86	3.66	0.55	0.00	0.55	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	26.23	7.60	1.52	0.76	0.00	0.76	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	28.56	29.75	5.95	1.19	1.19	0.00	1.19	1.19	0.00
colon, adult, pool1	10014-101C5	36.78	49.47	5.99	2.23	0.59	0.24	0.59	1.29	0.71
colon, fetal, donor1	10070-101I7	50.68	51.91	14.83	12.36	2.47	1.24	2.47	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	82.50	41.25	4.58	0.00	0.00	9.17	0.00	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	75.11	25.04	0.00	0.00	0.00	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	28.47	40.79	5.52	1.27	0.42	0.85	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	30.64	26.71	6.94	1.96	0.30	1.36	0.00	1.06	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	29.75	25.52	6.06	2.12	0.42	0.42	0.14	0.42	0.28
corpus callosum, adult, pool1	10042-101F6	63.91	27.86	2.65	1.33	0.44	1.33	1.99	0.11	0.33
cruciate ligament, donor2	10295-104G7	33.23	12.97	2.43	4.86	2.43	2.43	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	8.83	30.50	3.21	0.80	1.61	2.41	0.00	0.00	0.00
diencephalon, adult	10193-103E4	13.20	4.80	2.88	1.92	0.00	0.24	0.48	0.24	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	30.31	2.53	2.53	0.92	0.92	0.00	0.00	0.69	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	52.83	28.72	4.87	2.56	0.00	0.00	2.05	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	10.35	5.78	1.69	1.69	0.96	0.00	0.24	0.00	0.00
ductus deferens, adult	10196-103E7	24.42	26.91	6.98	1.50	1.50	1.00	0.50	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	28.80	28.80	5.76	5.76	0.00	0.00	2.88	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	57.38	31.63	6.62	7.36	2.94	0.00	0.74	2.21	0.00
dura mater, adult, donor1	10041-101F5	102.90	45.75	4.62	1.49	1.65	1.57	0.74	0.66	1.16
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	74.62	24.43	5.77	2.22	2.22	0.22	0.67	3.55	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	93.57	6.73	11.46	3.30	2.15	0.14	0.43	1.58	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	41.93	20.96	9.87	3.08	0.62	0.62	0.62	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	40.26	15.14	2.12	6.96	0.61	0.00	0.30	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	27.79	20.07	4.32	3.70	0.00	0.31	0.93	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	27.58	35.46	5.25	2.63	0.00	0.00	3.94	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	37.54	13.07	9.39	4.69	0.00	0.00	0.00	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	24.65	23.56	6.16	7.07	1.45	0.18	1.45	0.54	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	36.18	27.34	5.79	11.42	1.77	0.16	1.45	0.96	0.00
epidermoid carcinoma cell line:A431	10426-106D3	36.02	37.68	5.45	3.11	0.22	0.44	0.33	0.33	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	69.51	36.74	3.74	2.86	0.55	0.88	1.43	0.44	0.22
epididymis, adult	10197-103E8	31.82	24.70	7.12	4.81	0.84	1.26	0.42	1.26	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	15.61	9.40	2.13	4.44	0.53	0.53	0.00	0.35	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	3.93	3.15	0.00	0.39	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	28.70	22.93	10.48	5.77	0.79	0.52	1.97	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	42.62	34.74	8.66	7.09	0.89	0.49	1.57	0.79	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	29.69	27.56	7.06	5.94	0.78	0.78	1.79	0.34	0.00
esophagus, adult, pool1	10015-101C6	52.03	76.02	7.86	3.93	1.59	1.17	3.29	2.23	0.85
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	41.70	31.31	2.63	1.88	0.38	1.13	0.63	0.75	0.00
eye - muscle inferior rectus, donor1	10272-104E2	60.36	33.80	14.49	4.83	0.00	4.83	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	12.63	33.67	0.00	4.21	2.10	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	8.93	26.79	8.93	1.49	2.98	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	25.22	22.93	8.03	5.73	0.00	0.00	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	32.06	29.15	5.83	4.37	2.91	0.00	0.00	0.00	2.91
eye, fetal, donor1	10054-101G9	25.17	22.12	2.80	4.07	1.53	2.29	0.76	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	19.36	14.23	3.21	5.39	0.77	0.90	0.26	0.51	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	23.03	18.28	8.07	4.27	0.24	0.24	0.24	0.47	0.47
frontal lobe, adult, pool1	10040-101F4	29.74	12.95	1.22	0.66	0.47	0.84	0.28	0.00	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	36.63	35.13	10.21	7.21	2.40	0.30	1.20	0.60	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	62.63	21.21	2.38	3.02	0.18	1.01	0.91	0.37	0.00
gall bladder, adult	10198-103E9	79.67	70.50	10.62	6.52	3.86	1.21	2.41	2.66	0.24
gamma delta positive T cells, donor1	11937-126A2	85.90	7.52	5.37	8.05	0.54	0.54	1.07	1.07	1.61
gamma delta positive T cells, donor2	11938-126A3	125.12	11.20	11.58	2.99	0.75	1.49	0.75	1.87	3.73
gastric adenocarcinoma cell line:MKN1	10614-108G2	38.02	19.85	3.38	4.44	1.27	0.21	1.06	0.42	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	54.16	43.13	7.16	8.12	1.35	0.77	2.13	1.35	0.00
gastric cancer cell line:AZ521	10549-107H9	28.20	15.25	3.93	1.64	0.16	0.16	1.15	0.33	0.00
gastric cancer cell line:GSS	10560-108A2	21.97	25.63	0.92	6.41	0.00	3.66	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	18.73	14.16	0.69	1.37	0.69	0.23	0.69	0.46	0.00
giant cell carcinoma cell line:LU65	10487-107B1	50.72	24.55	9.87	6.54	1.38	1.72	1.03	0.46	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	49.27	32.05	5.46	2.24	0.28	0.42	0.42	0.70	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	19.70	34.92	7.73	5.99	0.25	0.50	1.25	0.50	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	48.45	9.08	3.80	3.91	0.11	0.42	0.11	0.32	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	40.87	9.55	3.79	2.39	0.14	0.84	0.56	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	46.58	8.61	3.97	2.43	0.33	0.55	0.11	0.22	0.00
glioma cell line:GI-1	10413-106B8	50.96	16.99	0.88	2.05	0.29	1.17	0.00	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	51.75	26.24	5.10	5.83	2.19	0.73	4.37	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	46.13	25.63	4.39	1.71	0.49	1.46	2.44	1.22	0.49
globus pallidus, adult, donor10258	10367-105F7	39.71	27.38	1.37	2.74	1.37	0.00	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	54.89	27.18	4.26	8.53	2.13	1.07	0.00	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	249.61	61.18	2.45	2.45	2.45	7.34	0.00	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	10.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	73.17	0.00	5.23	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	23.04	32.00	4.48	6.08	0.32	0.00	1.92	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	95.95	5.05	3.67	16.07	1.38	0.92	1.38	0.92	0.46
hIPS +CCl2, biol_rep2	14384-156C1	90.08	5.94	3.20	13.72	3.20	1.83	1.37	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	94.68	5.15	0.64	17.39	2.58	0.64	1.29	1.29	0.00
hIPS, biol_rep1	14380-156B6	71.86	0.00	1.44	11.50	2.87	0.00	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	79.56	6.86	4.12	24.69	4.12	3.43	0.69	0.69	0.00
hIPS, biol_rep3	14382-156B8	34.21	6.62	0.00	4.41	1.10	1.10	0.00	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	55.17	26.15	13.51	8.05	0.86	1.15	0.86	0.29	0.00
heart - mitral valve, adult	10205-103F7	34.08	41.86	7.47	5.38	0.60	0.60	0.30	0.90	0.30
heart - pulmonic valve, adult	10206-103F8	16.73	35.04	4.71	2.61	1.05	1.31	0.26	0.00	0.26
heart - tricuspid valve, adult	10207-103F9	53.29	144.05	40.80	7.49	1.67	4.16	2.50	2.50	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	20.00	54.07	5.31	8.16	0.61	1.63	0.41	0.82	0.20
heart, adult, diseased, donor1	10051-101G6	31.94	81.76	8.52	11.92	1.70	1.70	0.85	0.00	0.85
heart, adult, pool1	10016-101C7	23.46	59.33	6.67	1.15	0.00	0.69	0.69	0.23	0.46
heart, fetal, pool1	10046-101G1	35.42	48.46	2.46	0.82	0.62	4.00	0.92	0.51	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	21.29	14.81	2.78	4.32	0.31	0.62	0.62	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	47.57	49.95	9.51	13.08	1.19	0.00	1.19	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	72.26	42.32	14.03	9.17	0.88	1.44	1.77	1.55	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	79.74	44.30	13.23	13.47	0.73	2.43	1.82	0.73	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	81.45	49.82	10.71	10.00	1.41	2.43	2.53	0.71	0.10
hepatoma cell line:Li-7	10484-107A7	38.48	12.46	4.89	2.45	1.22	0.33	0.78	0.33	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	55.48	0.80	2.01	2.41	0.40	0.10	0.40	0.40	0.00
hippocampus - adult, donor10196	10169-103B7	31.23	24.60	4.73	5.68	0.95	0.95	2.84	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	28.98	15.72	2.45	0.82	0.20	1.63	1.43	0.20	0.00
hippocampus, adult, donor10258	10374-105G5	19.92	3.49	0.50	1.99	0.00	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	52.52	25.38	3.88	8.11	1.06	1.06	1.06	0.00	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	93.99	15.87	14.65	47.61	14.65	2.44	0.00	4.27	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	89.93	21.21	29.45	22.19	4.52	2.36	1.57	2.55	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	95.46	21.07	16.00	38.59	5.33	3.81	1.02	2.79	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	192.84	36.09	20.86	45.11	24.81	9.02	1.13	9.59	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	182.56	25.56	33.05	33.83	28.40	6.97	1.81	7.23	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	206.13	31.51	16.32	33.41	14.43	7.59	1.14	4.93	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	159.41	47.59	9.93	27.44	10.80	3.80	0.58	3.50	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	186.13	33.39	23.91	21.97	10.56	4.95	1.29	6.25	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	164.33	39.20	14.60	17.93	5.00	2.92	0.42	5.42	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	87.61	26.28	7.81	7.10	2.84	3.32	1.42	3.32	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	133.07	44.36	28.77	25.23	8.52	3.70	1.61	4.98	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	107.06	26.93	4.04	8.75	0.67	2.69	1.35	5.39	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	84.50	15.18	21.59	20.81	3.91	2.97	1.25	2.50	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	56.99	14.74	18.67	33.41	8.84	1.97	0.98	2.46	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	54.98	8.73	13.09	41.02	8.73	5.24	0.87	3.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	238.64	44.48	33.22	35.89	19.28	7.83	1.72	8.97	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	218.47	40.99	29.22	30.96	13.52	4.80	1.31	6.11	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	188.41	33.98	15.99	45.98	22.49	9.50	0.50	6.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	201.20	29.01	16.96	19.78	9.04	5.84	1.32	3.39	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	163.70	33.65	19.55	20.92	14.55	4.55	1.82	5.91	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	166.64	31.64	18.48	28.82	8.14	4.70	1.25	3.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	106.47	29.56	21.88	20.41	7.35	2.45	1.80	1.96	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	96.09	25.84	15.68	17.13	6.97	3.48	1.16	3.77	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	147.37	34.38	12.26	26.01	6.28	4.48	2.09	4.18	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	103.27	19.58	34.73	30.30	7.21	4.06	2.40	2.96	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	98.99	24.82	27.39	29.10	7.13	4.85	1.71	2.28	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	108.61	23.68	17.97	50.63	7.76	7.76	2.45	3.67	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	117.59	23.24	15.14	25.70	15.84	3.52	0.70	8.10	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	134.61	30.41	19.00	22.49	10.77	5.38	0.95	6.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	150.40	34.20	16.95	31.17	10.59	3.63	2.12	9.38	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	111.70	26.37	14.48	14.48	4.14	3.62	0.52	1.55	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	96.30	17.93	9.30	9.30	4.65	1.99	2.66	1.99	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	94.92	23.60	3.08	5.64	1.54	3.08	0.77	1.03	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	93.06	18.66	8.95	13.80	6.90	1.53	2.30	2.81	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	84.81	21.20	9.09	13.63	5.30	5.30	1.51	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	75.61	23.86	14.11	26.55	4.03	1.34	1.68	3.70	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	122.20	18.35	26.08	26.81	9.42	5.80	1.45	5.07	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	103.39	18.27	19.61	43.23	10.70	1.78	0.89	2.67	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	113.66	30.24	23.90	49.76	8.29	3.90	1.46	4.88	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	200.18	36.67	23.53	16.50	15.89	5.81	0.31	6.72	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	81.33	3.25	13.01	55.31	35.79	3.25	0.00	9.76	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	162.16	24.49	15.55	39.71	22.50	4.30	0.66	9.93	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	152.70	25.72	7.11	12.04	7.66	1.09	0.00	7.66	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	116.89	27.50	9.05	16.65	4.70	3.98	1.45	3.26	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	118.86	30.25	8.90	18.51	4.63	1.07	0.71	4.98	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	102.63	25.06	7.16	21.48	10.74	4.77	1.19	4.77	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	110.10	28.71	6.23	6.50	8.53	3.66	0.81	2.98	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	81.63	29.90	16.16	30.17	6.47	2.16	1.35	3.23	0.00
immature langerhans cells, donor1	11904-125F5	28.33	33.17	0.97	2.18	0.48	0.73	0.48	0.00	0.97
immature langerhans cells, donor2	11905-125F6	68.12	91.89	7.13	2.38	3.96	3.17	0.00	1.58	0.79
insula, adult, pool1	10039-101F3	41.92	17.22	1.70	0.95	0.09	0.76	0.66	0.00	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	12.36	9.43	0.98	3.25	0.33	0.00	0.98	0.00	0.00
kidney, adult, pool1	10017-101C8	28.14	39.75	6.61	3.10	1.10	0.80	1.60	0.30	0.20
kidney, fetal, pool1	10045-101F9	83.54	50.22	3.25	1.49	0.42	1.98	1.77	0.35	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	43.03	22.01	4.26	3.55	0.57	1.28	0.57	0.71	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	57.09	24.75	6.08	9.82	0.55	0.28	1.24	0.83	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	40.19	31.56	12.29	6.79	0.37	0.55	5.50	0.18	0.00
left atrium, adult, donor1	10079-102A7	28.33	15.26	0.00	2.72	1.63	1.09	0.00	0.54	0.00
left ventricle, adult, donor1	10078-102A6	22.25	37.92	2.53	8.09	1.52	1.01	1.52	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	16.42	15.60	1.64	3.01	0.00	1.37	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	19.04	8.62	3.59	2.16	2.16	0.00	0.00	0.72	0.00
leiomyoma cell line:15242A	10570-108B3	22.83	7.07	2.72	3.80	1.09	0.54	0.00	0.54	0.00
leiomyoma cell line:15425	10571-108B4	19.91	10.20	2.91	4.61	1.21	0.00	0.49	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	12.70	0.00	0.00	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	41.82	26.14	1.05	3.14	0.00	1.05	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	14.29	17.83	0.94	2.72	0.24	0.71	0.47	0.35	0.00
liposarcoma cell line:KMLS-1	10782-110G8	17.34	10.47	1.25	2.81	0.16	0.31	0.78	0.00	0.16
liposarcoma cell line:SW 872	10726-110A6	41.06	8.53	4.02	4.26	0.49	0.12	0.12	0.37	0.00
liver, adult, pool1	10018-101C9	21.55	30.14	4.38	2.27	0.32	0.65	0.32	1.62	0.16
liver, fetal, pool1	10086-102B5	30.10	21.64	2.82	2.82	0.00	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	57.31	49.14	9.48	6.27	2.04	1.31	2.04	0.58	0.58
locus coeruleus, adult, donor10252	10165-103B3	41.71	20.12	6.09	6.46	0.74	1.11	2.40	0.55	0.00
locus coeruleus, adult, donor10258	10375-105G6	9.87	20.31	4.23	7.62	3.10	1.13	0.56	0.56	0.00
locus coeruleus, newborn, donor10223	10362-105F2	35.75	23.13	2.52	13.04	5.05	0.84	2.10	1.68	0.42
lung adenocarcinoma cell line:A549	10499-107C4	30.45	7.75	3.18	1.66	0.14	0.14	0.55	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	36.54	13.10	0.69	1.38	0.00	0.00	0.69	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	54.57	44.82	2.37	3.69	0.53	2.37	1.05	0.40	0.00
lung, adult, pool1	10019-101D1	76.66	50.09	5.67	2.24	0.83	2.36	1.54	1.77	1.18
lung, fetal, donor1	10068-101I5	95.33	40.81	2.00	2.57	2.57	1.71	3.14	0.57	1.14
lung, right lower lobe, adult, donor1	10075-102A3	53.15	21.54	4.12	7.79	3.67	0.00	2.75	1.37	0.00
lymph node, adult, donor1	10077-102A5	46.39	10.41	2.84	3.31	1.42	0.47	0.95	0.95	1.42
lymphangiectasia cell line:DS-1	10727-110A7	24.77	27.18	4.60	11.40	0.66	1.75	1.10	0.00	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	23.85	0.91	1.66	0.60	0.30	0.30	0.15	0.15	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	41.63	47.57	4.25	7.65	0.00	0.00	4.25	0.85	0.00
mature adipocyte, donor1	12231-129F8	20.42	59.49	2.66	3.11	0.00	0.44	0.00	0.00	3.11
mature adipocyte, donor2	12232-129F9	26.15	50.22	0.83	2.28	0.00	1.25	0.42	0.00	2.70
mature adipocyte, donor3	12233-129G1	15.88	39.35	1.42	0.71	0.00	0.47	0.95	1.42	0.71
mature adipocyte, donor4	12234-129G2	23.16	27.64	0.79	0.79	0.26	1.05	1.32	0.00	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	17.87	45.27	2.14	2.62	0.48	1.19	2.14	0.48	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	30.46	21.43	1.13	2.26	4.51	0.00	2.26	3.38	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	29.43	12.87	2.21	2.02	0.55	0.92	1.66	0.92	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	13.66	4.13	2.54	5.08	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	31.13	9.81	0.43	5.54	1.71	1.28	0.00	0.43	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	27.51	21.43	4.22	4.73	1.35	1.01	1.35	1.01	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	25.25	16.55	2.76	0.85	0.21	1.49	0.64	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	11.56	1.93	0.00	1.93	0.00	1.93	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	0.00	14.35	28.71	28.71	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	43.43	24.77	5.03	7.54	0.00	1.79	1.08	0.00	0.36
medulla oblongata - adult, donor10196	10174-103C3	30.50	29.85	3.89	6.49	1.95	0.65	2.60	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	40.71	22.91	4.02	2.94	0.31	0.62	2.01	0.46	0.00
medulla oblongata, adult, pool1	10038-101F2	65.95	38.12	3.51	1.06	0.73	0.57	1.63	0.24	0.49
medulla oblongata, newborn, donor10223	10361-105F1	46.18	25.34	4.86	10.07	0.35	1.39	2.78	0.69	0.35
medulloblastoma cell line:D283 Med	10838-111E1	50.92	10.18	1.77	4.21	1.11	2.44	0.66	0.44	0.00
medulloblastoma cell line:ONS-76	10759-110E3	61.14	26.78	3.06	6.48	0.98	0.37	1.83	0.49	0.12
melanoma cell line:COLO 679	10514-107E1	54.05	41.40	6.76	4.60	2.16	0.57	1.01	2.01	0.14
melanoma cell line:G-361	10465-106H6	54.29	7.33	9.50	7.87	2.44	0.00	0.00	1.63	0.00
meningioma cell line:HKBMM	10691-109F7	22.25	10.13	7.06	5.43	0.36	0.36	0.18	0.36	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	101.33	7.05	11.46	3.52	0.88	0.00	1.76	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	108.10	31.37	16.07	9.07	2.59	4.93	1.04	1.30	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	25.62	11.05	1.07	2.30	0.77	0.00	0.46	0.61	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	23.27	8.91	0.73	0.91	0.18	0.18	0.00	0.55	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	24.02	7.04	0.41	1.24	0.41	0.00	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	31.33	23.60	2.11	2.11	0.42	0.14	0.56	0.56	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	21.95	8.47	1.54	1.35	0.00	0.19	0.19	0.00	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	45.12	19.43	6.25	5.55	0.69	0.69	0.00	1.39	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	17.51	13.73	0.69	1.03	0.17	0.34	0.17	0.51	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	40.26	19.67	1.38	1.61	0.35	0.46	0.92	0.81	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	20.03	16.18	2.25	2.25	0.40	0.40	0.27	0.40	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	21.20	12.29	1.76	1.49	0.27	0.27	0.54	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	9.82	9.25	1.28	0.43	0.43	0.00	0.28	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	20.42	7.90	3.62	2.31	1.32	0.00	0.33	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	16.19	9.82	0.83	0.83	0.14	0.28	0.00	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	22.34	12.92	3.49	2.79	1.40	0.35	0.35	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	9.19	7.15	0.61	1.22	0.20	0.00	0.00	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	20.13	11.14	1.44	2.52	0.36	0.00	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	16.86	7.45	1.14	1.03	0.00	0.10	0.52	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	14.82	6.84	1.82	3.19	0.23	0.00	0.46	0.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	9.65	4.20	0.42	0.42	0.00	0.00	0.42	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	14.05	12.10	1.20	1.34	0.30	0.15	0.45	0.60	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	16.72	12.87	1.66	1.93	0.79	0.18	0.18	0.70	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	12.89	9.20	1.10	1.84	0.00	0.37	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	16.88	10.30	3.15	3.15	1.14	0.29	0.57	0.86	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	24.42	14.74	2.95	4.63	1.26	0.42	0.42	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	18.27	10.05	0.91	1.83	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	19.18	8.95	1.02	2.81	0.51	0.51	0.26	1.28	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	21.20	14.92	3.93	1.83	0.00	0.26	0.00	0.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	25.57	11.40	2.46	3.08	1.23	0.62	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	22.59	11.53	2.12	2.35	0.71	0.00	0.24	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	24.03	9.48	3.05	3.05	0.00	0.00	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	16.11	6.29	3.54	1.57	0.00	0.00	0.00	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	15.29	6.49	1.85	2.32	0.46	0.00	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	14.13	8.08	0.29	1.44	0.29	0.00	0.29	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	13.83	9.37	0.45	1.12	0.00	0.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	12.02	6.01	0.72	0.48	0.48	0.00	0.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	8.07	2.20	0.73	0.73	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	16.11	6.38	2.01	1.68	0.34	0.34	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	11.87	3.68	1.23	1.64	0.41	0.00	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	9.88	5.15	0.86	0.43	0.43	0.00	0.43	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	8.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	10.33	5.16	5.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	10.72	7.15	0.97	1.62	0.00	0.00	0.00	0.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	7.27	2.91	1.45	2.91	0.00	1.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	8.00	9.60	5.86	2.13	0.00	0.53	1.07	0.53	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	9.81	8.18	2.45	1.64	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	12.05	7.39	2.72	2.72	0.39	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	2.10	2.10	4.20	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	9.93	7.95	0.99	2.98	0.00	0.00	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	4.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	5.34	7.12	1.78	1.78	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	4.87	2.44	3.66	0.00	1.22	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	10.77	1.90	0.63	0.63	1.27	0.00	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	4.83	5.17	0.69	1.03	0.00	0.00	0.00	1.03	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	15.04	4.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	7.98	7.98	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	3.44	3.44	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	6.93	7.33	1.63	2.44	0.00	0.00	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	11.92	7.15	2.38	2.38	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	5.90	7.07	4.13	2.95	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	5.61	4.68	4.36	2.18	0.00	0.31	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	16.04	4.01	1.34	8.02	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	8.28	2.37	1.18	5.91	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	5.14	2.57	5.14	2.57	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	6.88	8.95	1.38	4.13	0.00	0.00	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	0.99	7.42	2.47	1.98	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	7.85	2.24	1.12	3.36	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	7.00	5.72	1.91	1.27	0.64	0.00	0.64	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	5.64	2.82	1.21	3.22	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	2.18	4.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	2.53	2.53	1.27	1.27	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	3.64	1.82	0.61	0.61	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	4.94	0.82	1.65	2.47	0.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	9.52	8.14	2.58	0.40	0.20	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	14.60	10.06	6.49	2.27	0.65	0.32	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	13.24	6.11	4.07	7.13	0.00	0.00	0.00	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	24.76	17.80	0.77	0.77	0.00	0.00	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	17.72	14.41	4.96	3.78	0.00	0.47	0.24	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	63.94	13.21	9.04	7.18	0.93	0.23	0.46	0.46	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	8.55	8.55	8.55	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	15.31	8.84	0.72	2.26	0.51	0.10	0.31	0.10	0.10
mesothelioma cell line:Mero-25	10850-111F4	29.96	9.76	4.09	1.82	0.68	0.23	1.13	0.45	0.23
mesothelioma cell line:Mero-41	10851-111F5	78.48	21.02	6.60	4.65	0.73	0.49	0.73	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	39.41	11.74	2.21	5.98	1.11	0.00	1.11	1.11	0.00
mesothelioma cell line:Mero-82	10853-111F7	56.50	18.13	4.20	6.83	1.84	0.00	1.31	0.53	0.00
mesothelioma cell line:Mero-83	10854-111F8	25.36	10.04	1.87	2.21	0.85	0.00	0.34	0.51	0.00
mesothelioma cell line:Mero-84	10855-111F9	50.30	18.45	4.04	3.54	1.01	0.00	1.52	1.01	0.00
mesothelioma cell line:Mero-95	10856-111G1	53.21	16.56	3.52	3.31	1.24	1.04	0.83	0.62	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	23.52	16.23	3.48	2.65	0.83	0.50	0.66	0.50	0.00
mesothelioma cell line:NCI-H226	10846-111E9	23.17	10.50	4.34	2.71	1.09	0.00	0.18	0.54	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	33.65	10.76	5.12	3.59	0.85	0.17	0.17	0.17	0.17
mesothelioma cell line:NCI-H28	10845-111E8	48.86	10.69	5.34	4.07	1.78	1.02	0.76	1.27	0.00
mesothelioma cell line:No36	10857-111G2	31.64	6.52	3.91	1.63	0.65	0.00	0.00	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	20.86	8.67	1.63	1.90	0.54	0.00	0.27	0.81	0.00
migratory langerhans cells, donor1	11901-125F2	32.43	4.99	0.00	0.77	0.38	0.19	0.38	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	14.65	13.07	0.37	0.98	0.12	0.73	0.12	0.24	0.00
migratory langerhans cells, donor3	11903-125F4	20.46	6.10	0.36	0.90	0.36	0.36	0.00	0.54	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	25.14	2.61	4.90	4.57	1.63	0.33	0.33	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	24.58	9.75	4.24	7.42	1.91	1.06	0.00	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	56.67	37.09	7.83	7.83	0.00	0.23	1.84	0.23	0.92
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	30.83	23.79	2.28	5.71	1.33	0.76	0.57	1.14	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	31.05	0.00	2.22	0.92	0.00	0.00	0.18	0.18	0.00
myeloma cell line:PCM6	10474-106I6	27.28	37.95	14.83	12.06	1.38	2.17	1.58	1.19	9.29
myxofibrosarcoma cell line:MFH-ino	10600-108E6	30.44	10.65	3.55	4.06	0.51	1.01	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	79.83	48.45	8.83	15.69	1.57	1.37	1.37	0.78	2.16
nasal epithelial cells, donor1, tech_rep1	12226-129F3	27.52	21.06	4.46	3.12	0.33	0.33	2.12	0.33	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	29.86	21.25	3.31	3.02	0.37	0.15	1.54	0.29	0.07
nasal epithelial cells, donor2	12227-129F4	41.40	24.84	4.97	1.66	0.55	0.55	1.10	1.66	1.66
neuroblastoma cell line:CHP-134	10508-107D4	84.66	11.27	7.82	4.37	0.69	3.68	0.46	0.69	0.00
neuroblastoma cell line:NB-1	10539-107G8	74.83	33.68	7.67	4.86	0.37	3.74	1.12	0.19	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	47.24	3.16	5.69	6.12	0.63	1.69	0.42	1.05	0.00
neuroblastoma cell line:NH-12	10555-107I6	100.82	10.99	5.40	9.88	1.49	1.86	1.49	0.37	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	108.41	1.90	4.74	9.49	3.56	0.47	0.71	0.47	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	71.27	17.90	5.54	17.42	1.58	0.95	0.32	1.74	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	28.98	2.82	4.43	9.66	1.01	1.41	0.20	0.20	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	48.32	2.54	3.81	4.45	0.00	0.00	1.27	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	21.83	19.43	2.93	7.19	0.00	0.00	1.06	0.53	0.00
neutrophil PMN, donor1	12133-128D9	282.62	44.62	14.87	0.00	0.00	0.00	0.00	0.00	14.87
neutrophil PMN, donor2	12137-128E4	66.40	13.28	13.28	0.00	0.00	0.00	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	132.59	28.41	0.00	9.47	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	75.94	11.16	2.20	0.85	0.17	1.69	0.00	0.34	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	53.63	28.02	2.40	0.00	0.00	1.60	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	29.82	33.98	4.81	7.69	1.60	0.64	0.00	0.32	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	41.25	15.50	14.71	4.47	1.58	0.26	0.53	1.31	0.00
nucleus accumbens, adult, pool1	10037-101F1	34.96	14.90	1.87	0.94	0.28	0.94	0.75	0.09	0.28
occipital cortex - adult, donor10196	10172-103C1	26.78	18.54	0.00	2.06	2.06	2.06	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	38.91	21.47	2.95	3.49	1.88	1.07	1.88	0.54	0.00
occipital cortex, newborn, donor10223	10355-105E4	37.49	16.01	3.28	5.10	0.36	1.09	0.36	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	31.49	9.71	1.57	3.41	1.84	1.31	1.05	1.05	0.00
occipital lobe, fetal, donor1	10073-102A1	157.91	8.58	5.58	12.01	10.73	6.87	0.86	2.57	0.43
occipital pole, adult, pool1	10036-101E9	32.25	14.66	1.42	0.47	0.16	2.21	0.55	0.39	0.24
olfactory region, adult	10195-103E6	19.49	7.07	3.06	3.06	0.57	0.57	0.38	0.38	0.19
optic nerve, donor1	10277-104E7	54.03	14.01	8.00	6.00	2.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	38.16	29.16	3.19	0.80	0.80	0.11	0.46	0.57	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	29.54	6.05	1.79	0.96	0.14	0.27	0.14	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	39.62	16.59	3.73	3.89	1.52	0.00	1.19	0.68	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	34.31	25.87	5.43	5.54	0.69	0.12	1.27	1.16	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	36.75	14.40	5.29	4.12	0.29	0.59	0.59	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	38.31	16.82	8.41	3.74	0.00	0.00	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	30.54	11.03	1.70	1.91	1.06	0.42	0.00	0.21	0.00
ovary, adult, pool1	10020-101D2	61.41	67.78	4.80	1.66	1.40	2.62	1.92	2.27	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	23.10	21.08	6.42	7.15	0.18	0.18	1.65	0.00	0.00
pancreas, adult, donor1	10049-101G4	36.68	18.81	0.94	3.76	0.00	0.94	1.88	3.76	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	57.30	19.29	15.09	10.34	2.24	0.28	0.28	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	44.63	16.18	6.64	5.62	1.70	0.00	0.51	0.68	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	37.59	35.43	3.15	3.15	0.17	0.66	0.50	0.50	0.17
paracentral gyrus, adult, pool1	10035-101E8	37.98	18.40	1.92	1.01	0.55	2.20	1.10	0.46	0.55
parietal cortex, adult, donor10258	10373-105G4	27.16	4.40	2.20	1.47	0.00	0.00	0.00	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	24.45	15.99	0.00	2.82	0.94	0.00	2.82	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	28.50	13.97	3.14	0.86	0.57	0.57	2.00	0.57	0.00
parietal lobe, adult, pool1	10034-101E7	30.75	18.33	1.67	0.97	0.35	1.76	0.62	0.35	0.09
parietal lobe, fetal, donor1	10072-101I9	155.17	10.67	7.76	20.37	7.76	2.91	0.97	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	52.71	23.18	7.10	9.72	1.12	1.12	0.37	0.37	0.00
parotid gland, adult	10199-103F1	13.57	20.97	4.32	3.08	0.62	0.62	0.00	0.00	0.62
penis, adult	10200-103F2	34.38	28.47	10.21	4.30	1.61	1.07	0.00	1.61	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	52.81	2.05	5.39	3.90	0.19	0.56	0.37	0.00	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	38.03	24.91	4.23	7.14	1.02	0.44	0.44	0.44	0.15
pineal gland - adult, donor10196	10179-103C8	10.32	39.35	3.23	3.23	3.23	6.45	3.23	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	11.25	25.47	1.18	2.37	0.00	2.96	2.37	1.18	0.00
pineal gland, adult, donor10258	10377-105G8	10.66	20.69	1.88	7.52	0.63	1.25	0.00	1.25	0.00
pituitary gland - adult, donor10196	10180-103C9	30.35	90.05	2.02	6.07	1.01	1.01	2.02	2.02	0.00
pituitary gland, adult, donor10252	10162-103A9	42.74	68.80	2.08	5.21	1.56	5.73	4.69	2.08	0.00
pituitary gland, adult, donor10258	10378-105G9	23.83	73.21	2.55	9.36	5.11	1.70	1.70	0.85	0.00
placenta, adult, pool1	10021-101D3	27.31	39.13	4.19	3.01	0.65	1.08	2.47	0.43	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	46.48	14.70	2.91	4.90	0.79	0.26	0.53	0.79	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	35.95	12.30	2.18	1.71	0.62	0.31	0.16	0.62	0.00
pons, adult, pool1	10033-101E6	32.79	19.71	1.89	0.52	0.52	1.38	0.34	0.26	0.17
postcentral gyrus, adult, pool1	10032-101E5	35.04	13.86	2.62	0.44	0.00	1.66	0.61	0.35	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	98.30	25.10	4.18	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	42.53	22.14	8.01	6.99	0.87	0.00	0.15	0.73	0.00
prostate cancer cell line:PC-3	10439-106E7	13.25	12.16	3.45	4.54	0.54	0.54	1.09	0.00	0.00
prostate, adult, pool1	10022-101D4	47.16	29.75	2.72	0.82	0.82	1.00	1.00	0.63	0.27
putamen, adult, donor10196	10176-103C5	50.75	28.33	6.14	3.54	1.42	1.42	0.71	1.89	0.24
putamen, adult, donor10252	10152-102I8	23.53	3.92	5.88	3.92	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	36.06	2.19	3.28	3.28	3.28	1.09	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	14.98	6.52	0.48	0.24	0.00	0.24	0.72	0.24	0.24
putamen, newborn, donor10223	10365-105F5	28.49	7.50	4.50	5.25	1.50	0.00	1.50	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	28.22	63.42	18.62	6.98	1.16	0.29	0.29	0.00	0.00
rectum, fetal, donor1	10067-101I4	47.29	19.47	1.39	4.17	0.00	0.00	4.17	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	29.89	20.14	2.33	0.85	0.00	0.21	0.21	0.64	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	2.90	1.66	2.07	0.83	0.00	0.00	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	49.50	42.94	4.08	1.79	0.40	2.68	0.70	0.70	0.30
retinoblastoma cell line:Y79	10475-106I7	47.54	11.95	8.83	5.72	1.04	4.94	0.00	0.78	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	37.99	7.25	2.95	3.32	0.49	0.37	0.00	0.25	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	39.65	11.81	7.31	3.37	0.00	0.56	0.56	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	46.23	28.04	8.34	5.30	0.76	1.52	1.52	0.76	0.00
salivary acinar cells, donor1	11771-123I7	31.56	14.24	1.62	2.91	0.65	0.00	0.32	0.49	0.00
salivary acinar cells, donor2	11772-123I8	25.20	20.24	1.51	2.20	0.83	0.28	0.28	0.55	0.00
salivary acinar cells, donor3	11773-123I9	25.16	38.40	6.62	0.00	0.66	1.32	1.99	0.00	0.00
salivary gland, adult, pool1	10093-102C3	18.87	17.73	1.72	0.57	0.00	0.00	1.14	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	29.26	12.14	3.54	2.28	0.34	0.59	0.17	0.25	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	20.57	11.99	3.41	2.70	0.47	0.35	0.12	0.24	0.12
seminal vesicle, adult	10201-103F3	39.15	48.67	14.81	7.41	1.59	1.59	1.06	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	27.21	31.58	3.64	6.07	1.46	0.97	1.94	0.97	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	35.73	17.36	2.77	5.79	1.01	0.25	1.01	1.26	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	43.15	13.05	10.04	11.04	2.01	0.00	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	81.26	44.86	13.57	9.94	0.54	1.07	3.90	0.81	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	9.95	14.59	2.10	0.88	0.44	0.33	0.00	0.00	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	44.90	30.58	4.90	3.35	0.39	0.65	0.90	1.03	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	11.35	95.76	19.15	13.48	3.55	2.84	0.71	2.84	0.71
skeletal muscle, adult, pool1	10023-101D5	23.03	130.13	9.83	4.20	1.80	1.44	0.96	3.72	0.48
skeletal muscle, fetal, donor1	10066-101I3	22.11	16.08	4.02	0.00	0.00	0.00	0.00	1.01	0.00
skin, adult, donor1	10074-102A2	20.36	40.71	0.00	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	32.19	25.88	2.52	5.05	0.63	5.05	1.89	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	0.00	6.67	0.33	0.67	0.00	0.33	0.00	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	118.52	78.49	11.03	17.34	4.73	3.78	1.58	1.89	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	6.75	8.10	1.54	3.08	0.39	0.77	1.35	0.39	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	29.17	9.89	2.14	1.98	0.33	0.33	0.16	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	19.46	4.99	1.29	1.77	0.48	1.13	0.48	0.16	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	0.00	18.52	2.18	1.53	0.00	1.74	0.00	0.44	0.44
small intestine, adult, pool1	10024-101D6	47.78	98.18	12.06	6.57	3.58	3.11	0.72	4.18	0.36
small intestine, fetal, donor1	10064-101I1	41.52	32.19	3.93	11.30	2.46	0.98	2.46	0.74	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	63.09	28.21	7.18	6.15	2.05	0.51	1.54	2.56	0.00
smooth muscle, adult, pool1	10048-101G3	24.55	20.68	1.55	3.10	0.78	2.58	1.03	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	52.80	53.60	4.56	5.90	0.27	0.80	1.07	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	40.60	35.33	6.19	5.51	1.15	1.61	2.06	0.46	0.69
spinal cord, adult, donor10252	10159-103A6	40.61	17.74	1.97	1.58	1.58	0.79	0.79	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	15.22	0.69	0.69	2.77	0.00	0.69	1.38	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	53.06	26.22	4.27	3.05	0.00	1.83	2.44	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	41.33	13.78	0.46	5.51	0.92	0.46	0.46	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	23.45	22.10	3.14	2.69	0.00	0.15	0.15	0.30	0.00
spleen, adult, pool1	10025-101D7	69.16	39.98	8.15	3.41	1.43	1.21	0.55	1.43	1.43
spleen, fetal, pool1	10044-101F8	71.11	34.32	2.86	1.43	0.56	2.22	1.67	0.79	1.27
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	30.43	9.42	2.38	1.86	0.21	0.31	0.31	0.41	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	40.06	39.49	13.67	6.27	0.38	0.38	2.47	0.76	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	17.82	38.09	1.05	9.44	2.80	0.00	1.40	0.70	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	52.38	47.30	4.30	9.38	0.78	1.17	1.56	1.17	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	77.89	41.08	13.73	12.27	1.35	1.69	0.79	1.58	0.68
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	17.37	21.18	1.27	2.12	1.27	0.00	0.85	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	21.15	14.38	1.69	3.38	0.00	0.42	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	91.85	37.38	9.61	12.82	0.00	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	29.05	35.89	6.27	3.99	0.57	0.00	1.14	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	108.55	108.55	108.55	162.82	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	33.65	13.92	3.95	4.78	0.62	1.04	2.08	0.83	0.00
substantia nigra, adult, donor10258	10371-105G2	14.48	5.17	0.52	5.17	0.00	0.00	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	39.57	18.37	4.24	13.42	1.41	0.00	2.12	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	86.66	23.16	10.32	9.86	1.60	1.83	1.15	1.38	0.00
temporal lobe, adult, pool1	10031-101E4	43.83	15.43	2.46	0.93	0.25	0.85	0.68	0.68	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	130.34	12.11	9.26	12.82	7.83	7.12	0.71	2.85	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	136.70	9.67	17.14	8.79	1.76	3.08	2.64	2.64	0.44
tenocyte, donor1	11763-123H8	36.31	16.06	5.59	9.43	1.75	1.05	0.35	1.05	0.00
tenocyte, donor2	11765-123I1	34.72	14.12	3.82	9.54	0.76	0.00	1.14	0.00	0.00
tenocyte, donor3	11768-123I4	30.39	12.23	5.19	7.41	1.48	0.37	0.00	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	65.09	10.37	6.29	9.52	2.04	2.04	1.02	0.85	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	44.39	25.59	4.32	6.63	2.16	2.62	0.62	1.54	0.15
teratocarcinoma cell line:PA-1	10807-111A6	62.30	13.17	2.94	5.89	1.86	3.10	0.31	0.93	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	91.53	29.45	7.49	12.31	2.67	1.78	3.30	1.65	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	169.04	36.68	6.81	7.94	1.89	1.51	3.78	3.40	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	160.98	55.51	8.40	9.82	2.73	0.65	7.09	2.29	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	53.74	12.70	3.91	8.14	1.63	0.33	0.33	1.95	0.00
testis, adult, pool1	10026-101D8	33.82	27.92	3.97	1.40	0.54	1.61	2.25	3.76	0.11
testis, adult, pool2	10096-102C6	28.87	18.49	4.51	4.51	0.45	0.45	1.80	1.35	0.00
thalamus - adult, donor10196	10168-103B6	50.78	34.22	6.62	3.31	0.00	2.21	2.21	0.00	0.00
thalamus, adult, donor10252	10154-103A1	30.01	17.03	2.50	1.56	0.00	0.31	0.78	0.31	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	9.24	7.70	0.00	1.54	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	12.52	18.61	2.47	6.26	1.98	0.66	1.15	0.49	0.00
thalamus, newborn, donor10223	10366-105F6	27.62	7.48	4.60	19.56	0.58	1.15	0.00	0.58	0.00
throat, adult	10209-103G2	33.21	69.41	8.49	2.00	1.50	1.25	3.25	1.75	0.25
throat, fetal, donor1	10061-101H7	25.60	20.11	3.35	6.40	1.83	1.83	0.30	0.61	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	62.60	0.60	3.38	2.78	0.40	0.00	0.20	0.79	0.00
thymus, adult, pool1	10027-101D9	108.46	7.06	4.57	1.69	0.99	0.60	0.80	1.19	0.00
thymus, fetal, pool1	10043-101F7	148.79	21.09	4.36	2.18	0.52	0.73	0.62	1.25	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	21.27	13.43	3.19	2.13	0.66	0.66	0.53	0.13	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	44.28	25.56	3.07	5.87	1.26	0.28	0.56	0.28	0.14
thyroid, adult, pool1	10028-101E1	25.47	34.90	3.55	1.87	0.65	0.65	0.65	0.75	0.37
thyroid, fetal, donor1	10060-101H6	34.01	44.56	7.12	8.17	5.27	2.11	1.32	0.26	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	58.51	80.07	33.88	3.08	3.08	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	35.12	66.05	9.77	4.42	1.86	1.16	1.63	1.40	0.23
tongue, fetal, donor1	10059-101H5	16.55	52.41	5.52	15.76	2.76	0.79	0.79	0.79	0.00
tonsil, adult, pool1	10047-101G2	81.34	72.93	4.21	2.10	0.70	1.40	2.30	1.00	1.90
trachea, adult, pool1	10029-101E2	62.41	48.92	4.58	2.94	0.90	1.23	1.31	1.64	0.57
trachea, fetal, donor1	10058-101H4	29.62	31.54	3.46	5.77	3.46	1.15	1.54	1.54	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	31.18	13.11	8.15	6.38	0.35	0.00	0.00	1.42	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	86.52	32.73	4.05	3.24	0.61	1.01	1.11	0.41	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	34.63	38.86	7.99	7.52	3.60	1.88	0.63	1.10	0.00
tridermal teratoma cell line:HGRT	10694-109G1	30.44	38.05	38.05	9.51	0.00	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	44.95	27.68	2.12	5.33	1.69	0.51	0.76	0.93	0.08
umbilical cord, fetal, donor1	10057-101H3	35.47	31.30	0.00	6.26	4.17	0.00	6.26	0.00	0.00
uterus, adult, pool1	10100-102D1	33.44	13.48	0.85	0.68	0.17	0.68	0.51	0.17	0.34
uterus, fetal, donor1	10055-101H1	19.97	12.80	3.58	4.61	0.00	1.02	2.05	0.00	0.00
vagina, adult	10204-103F6	25.20	30.37	2.58	1.29	0.65	0.00	2.58	0.65	1.29
vein, adult	10191-103E2	47.57	21.26	4.16	2.63	1.32	0.44	0.22	1.32	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	14.42	5.61	2.14	2.67	0.00	0.27	0.00	0.27	0.00